New Jersey Institute of Technology

Digital Commons @ NJIT
Dissertations

Theses and Dissertations

Spring 2014

Computational methods for the analysis of next
generation sequencing data
Wei Wang
New Jersey Institute of Technology

Follow this and additional works at: https://digitalcommons.njit.edu/dissertations
Part of the Computer Sciences Commons
Recommended Citation
Wang, Wei, "Computational methods for the analysis of next generation sequencing data" (2014). Dissertations. 169.
https://digitalcommons.njit.edu/dissertations/169

This Dissertation is brought to you for free and open access by the Theses and Dissertations at Digital Commons @ NJIT. It has been accepted for
inclusion in Dissertations by an authorized administrator of Digital Commons @ NJIT. For more information, please contact
digitalcommons@njit.edu.

Copyright Warning & Restrictions
The copyright law of the United States (Title 17, United
States Code) governs the making of photocopies or other
reproductions of copyrighted material.
Under certain conditions specified in the law, libraries and
archives are authorized to furnish a photocopy or other
reproduction. One of these specified conditions is that the
photocopy or reproduction is not to be “used for any
purpose other than private study, scholarship, or research.”
If a, user makes a request for, or later uses, a photocopy or
reproduction for purposes in excess of “fair use” that user
may be liable for copyright infringement,
This institution reserves the right to refuse to accept a
copying order if, in its judgment, fulfillment of the order
would involve violation of copyright law.
Please Note: The author retains the copyright while the
New Jersey Institute of Technology reserves the right to
distribute this thesis or dissertation
Printing note: If you do not wish to print this page, then select
“Pages from: first page # to: last page #” on the print dialog screen

The Van Houten library has removed some of the
personal information and all signatures from the
approval page and biographical sketches of theses
and dissertations in order to protect the identity of
NJIT graduates and faculty.

ABSTRACT
COMPUTATIONAL METHODS FOR THE ANALYSIS OF NEXT
GENERATION SEQUENCING DATA
by
Wei Wang
Recently, next generation sequencing (NGS) technology has emerged as a powerful
approach and dramatically transformed biomedical research in an unprecedented scale.
NGS is expected to replace the traditional hybridization-based microarray technology
because of its affordable cost and high digital resolution. Although NGS has significantly
extended the ability to study the human genome and to better understand the biology of
genomes, the new technology has required profound changes to the data analysis. There
is a substantial need for computational methods that allow a convenient analysis of these
overwhelmingly high-throughput data sets and address an increasing number of
compelling biological questions which are now approachable by NGS technology.
This dissertation focuses on the development of computational methods for NGS
data analyses. First, two methods are developed and implemented for detecting variants
in analysis of individual or pooled DNA sequencing data. SNVer formulates variant
calling as a hypothesis testing problem and employs a binomial-binomial model to test
the significance of observed allele frequency by taking account of sequencing error.
SNVerGUI is a GUI-based desktop tool that is built upon the SNVer model to facilitate
the main users of NGS data, such as biologists, geneticists and clinicians who often lack
of the programming expertise. Second, collapsing singletons strategy is explored for
associating rare variants in a DNA sequencing study. Specifically, a gene-based genomewide scan based on singleton collapsing is performed to analyze a whole genome

sequencing data set, suggesting that collapsing singletons may boost signals for
association studies of rare variants in sequencing study. Third, two approaches are
proposed to address the 3’UTR switching problem. PolyASeeker is a novel
bioinformatics pipeline for identifying polyadenylation cleavage sites from RNA
sequencing data, which helps to enhance the knowledge of alternative polyadenylation
mechanisms and their roles in gene regulation. A change-point model based on a
likelihood ratio test is also proposed to solve such problem in analysis of RNA
sequencing data. To date, this is the first method for detecting 3’UTR switching without
relying

on

any

prior

knowledge

of

polyadenylation

cleavage

sites.
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CHAPTER 1
INTRODUCTION

The past few years have seen a dramatic development in sequencing technology, which has
made the per-base cost of DNA sequencing plummet by ~100,000-fold over the past
decade, far outpacing Moore’s law of technological advance in the semiconductor industry
(Lander, 2011). Because of affordable cost and high digital resolution, the new or “next
generation” sequencing (NGS) technology is replacing the traditional hybridization-based
microarray technology. And this new engine has been ‘turbo-charged’ by several orders of
magnitude compared to its predecessor (Figure 1.1) since the basic mechanisms for data
generation have been changed radically, producing far more sequence reads per instrument
run and at a significantly lower expense (Mardis, 2011).

Figure 1.1 Changes in instrument capacity over the past decade.
Source: (Mardis, 2011)
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Table 1.1 Sequencing Platform Comparison
Roche/454

Library
amplificati
on method

emPCR on bead
surface

Sequencing
method

Polymerase-media
ted incorporation
of unlabelled
nucleotides

Detection
method

Light emitted from
secondary
reactions initiated
by release of PPi

Post
incorporati
on method

NA (unlabelled
nucleotides are
added in
base-specific
fashion, followed
by detection)
Error model Substitution errors
rare,
insertion/deletion
errors at
homopolymers
Read length 400 bp/variable
(fragment/p length mate pairs
aired end)

Life
Technologies
SOLiD
emPCR on bead
surface

Illumina
Hi-Seq 2000

Enzymatic
amplification
on glass
surface
Ligase-mediated
Polymeraseaddition of 2-base mediated
encoded
incorporation
fluorescent
of
oligonucleotides
end-blocked
fluorescent
nucleotides

Pacific
Biosciences RS
NA (single
molecule
detection)

Chemical
cleavage of
fluorescent
dye and 3′
blocking
group
End of read
End of read
substitution errors substitution
errors

Polymerase-medi
ated
incorporation of
terminal
phosphate
labelled
fluorescent
nucleotides
Real time
detection of
fluorescent dye in
polymerase active
site during
incorporation
NA (fluorescent
dyes are removed
as part of PPi
release on
nucleotide
incorporation)
Random
insertion/deletion
errors

75 bp/50+25 bp

>1,000 bp

Fluorescent
emission from
ligated
dye-labelled
oligonucleotides

Fluorescent
emission from
incorporated
dye-labelled
nucleotides

Chemical
cleavage removes
fluorescent dye
and 3′ end of
oligonucleotide

150 bp/100+1
00 bp

Source: (Mardis, 2011)

Several platforms have been developed using the so called “massively parallel”
sequencing technology. Although each instrument is distinctly different in its specifics, as
showed in Table 1.1 (Mardis, 2011), all massively parallel devices share certain attributes:
First, the initial preparatory steps are fewer and simpler to perform than for Sanger
sequencing. Instead of a bacterial cloning step followed by DNA isolation, massively
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parallel sequencing begins with the production of a library formed by ligating
platform-specific synthetic DNAs (adapters) onto the ends of the fragment population to be
sequenced. Second, all platforms require the library fragments to be amplified on a solid
surface (either a glass slide or a microbead) by a polymerase-mediated reaction that
produces many copies of each single library fragment. Amplification is needed so that the
ensuing sequencing reactions produce sufficient signal for detection by the instrument's
optical system. However, this step also provides a source of sequencing error that is
perpetuated through the downstream processes, because polymerases are never 100%
accurate. Third, these instruments perform sequencing reactions as an orchestrated series
of repeating steps that are performed and detected automatically. The specifics of the DNA
sequencing reaction are different for each platform, emphasizing the amazing range of
innovation in chemistry, molecular biology and engineering required to produce sequence
information from hundreds of thousands to hundreds of millions of DNA molecules
simultaneously.

For

example,

the

Roche/454

instrument

detects

each

polymerase-catalysed nucleotide incorporation event by a downstream series of reactions
that produce light (‘pyrosequencing’), initiated by the pyrophosphate molecules released
on nucleotide incorporation. The Life Technologies SOLiD uses a unique DNA
ligase-mediated process that, through multiple rounds of template-directed ligation,
sequences each nucleotide twice. The Illumina sequencer incorporates fluorescently
labelled nucleotides that are chemically blocked such that only one nucleotide
incorporation event occurs per fragment population per sequencing cycle. Regardless of
the details, massively parallel sequencing reactions are distinguished by the fact that they
occur in a nucleotide-by-nucleotide stepwise fashion, rather than by discrete separation and
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detection (in a 96-at-a-time fashion) of already produced Sanger sequencing reaction
products on a capillary instrument. The fourth shared feature of these systems is the ability
to obtain sequence information from both the ends of the DNA fragments comprising the
sequencing library. Depending on the instrument system and the library construction
approach used, one can either sequence at both ends of linear fragments (‘paired end
sequencing’) or from both ends of previously circularized fragments (‘mate pair
sequencing’).
There are many applications have been conducted by taking the unprecedented
advantages of NGS. According to (Lander, 2011), an early application of massively
parallel sequencing was to create ‘epigenomic maps’, showing the locations of specific
DNA modifications, chromatin modifications and protein-binding events across the human
genome. Chromatin modification and protein binding can be mapped by chromatin
immunoprecipitation-sequencing (ChIP-Seq) (Barski, et al., 2007; Mikkelsen, et al.,
2007), and the sites of DNA methylation can be found by sequencing DNA in which the
methylated cytosines have been chemically modified (Methyl-Seq) (Meissner, et al.,
2008). Next, as the technology has improved, the focus has turned to re-sequencing human
samples to study inherited variation or somatic mutations. One can re-sequence the whole
genome (Bentley, et al., 2008) to varying degrees of coverage or use hybridization-capture
techniques (Okou, et al., 2007) to re-sequence a targeted subset, such as the protein-coding
sequences (referred to as the ‘exome’). Furthermore, sequencing is also being extensively
applied to RNA transcripts (RNA-Seq), to count their abundance, identify novel splice
forms or spot mutations (Mortazavi, et al., 2008). These applications have great impact on
genomics research and allow to not only understand the structure of genomes and the
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biology of genomes, but also further understand the biology of disease, advance the science
of medicine in the near future, in addition to improve the effectiveness of healthcare
ultimately (Green and Guyer, 2011), which is represented in Figure 1.2.

Figure 1.2 Schematic representations of accomplishments across five domains of
genomics research.
Source: (Green and Guyer, 2011)

Although next generation sequencing have significantly extended the ability to
study the human genome and to better understand the biology of genomes, the new
technology has required profound changes to the data analysis pipelines than those of
previous technology. For example, how to handle the huge amount of data, how to deal
with the error profiles of the sequencing platforms and how to model the significant
decrease in the read length become more challenging. These challenges have resulted in a
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revitalization of the bioinformatics-based pursuit for the analysis of next generation
sequencing data at all levels, in order to address an increasing number of compelling
biological questions that are now approachable by NGS technology.
This dissertation focuses on the development of computational methods for next
generation sequencing analysis. First, two methods are developed and implemented for
detecting variants in analysis of individual or pooled NGS data. SNVer formulates variant
calling as a hypothesis testing problem and employs a binomial-binomial model to test the
significance of observed allele frequency by taking account of sequencing error in NGS.
SNVerGUI is a GUI-based desktop tool that is built upon the SNVer model in order to
facilitate the main users of NGS data, such as biologists, geneticists and clinicians who
often lack of the programming expertise.

Second, collapsing singletons strategy is

explored for associating rare variants in a NGS study. Specifically, a gene-based
genome-wide scan based on singleton collapsing is performed to analyze a whole genome
sequencing data, suggesting that collapsing singletons may boost signals for association
studies in sequencing data. Third, two approaches are proposed to solve the problem of
identification of 3’UTR length changes in RNA-Seq data. On one hand, PolyASeeker, is a
novel bioinformatics pipeline for identifying polyadenylation cleavage sites from
RNA-Seq data. Followed by the conventional method using Fisher’s exact test, the 3’UTR
switching can be detected. On the other hand, a change-point model based on a likelihood
ratio test has been proposed, which is the first available method to allow alternative
cleavage and polyadenylation (APA) analysis without relying on any PolyA information
and hence is more powerful and accurate in the APA studies than the traditional method.

6

This dissertation is organized in the following manner. Chapter 2 discusses the
background and related work of variant calling and association study in DNA-Seq analysis,
together with the identification of 3’UTR length changes from RNA-Seq data. Chapters 3
and 4 introduce two proposed methods, SNVer and SNVerGUI, for variant detection in
analysis of individual or pooled sequencing data. Chapter 5 demonstrates that collapsing
singletons may boost signal for associating rare variants in sequencing study. Chapters 6
and 7 propose two methods, PolyASeeker and a change-point model-based approach, for
identifying 3’UTR length changes in RNA-Seq studies. Finally, Chapter 8 summarizes the
contribution of this dissertation and discusses future directions for research.
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CHAPTER 2
BACKGROUD

2.1 Variant Detection by DNA-Seq
For genetics studies, NGS holds the promise to revolutionize genome-wide association
studies (GWAS). The recently completed phase of GWAS mainly addresses common
SNPs with minor allele frequency > 5%, based upon the common disease/common variant
(CD/CV) hypothesis (Manolio, et al., 2009). However, the identified common variants
explain only a small proportion of heritability (Hindorff, et al., 2009). Rare variants
therefore have been hypothesized to account for the missing heritability (Dickson, et al.,
2010; Wang, et al., 2010). To identify rare variants, a direct and more powerful approach is
to sequence a large number of individuals (Li and Leal, 2009). This line of thought also
implicitly motivates the recent 1000 Genomes Project, which will sequence the genomes of
1,200 individuals of various ethnicities by NGS (Hayden, 2008). It is expected to extend
the catalogue of known human variants down to a frequency near 1%.
Although the cost of whole-genome or exome sequencing of all enrolled subjects is
prohibitively high now, such studies will eventually be carried out in a manner similar to
GWAS with very large sample sizes (Cirulli and Goldstein, 2010). While the cost is being
brought down to as low as $1000 for sequencing a whole genome (Service, 2006), in the
interim, a cost-effective strategy has to be taken in order to take the full advantage of NGS.
Such issues with cost and labor are not new as similar problems were confronted in the
early expensive stage of GWAS and were circumvented by focusing on small candidate
regions and the use of pooling of genomic DNAs (Norton, et al., 2004; Sham, et al., 2002).
Borrowing the same idea, many targeted re-sequencing applications utilizing pooling have
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been seen in the past few years (Calvo, et al., 2010; Momozawa, et al., 2011; Nejentsev, et
al., 2009; Out, et al., 2009).
The first-step analysis of NGS data for genetics study is often to identify genomic
variants among sequenced samples. Quite a few SNP calling tools have been implemented
to identify SNPs from sequencing of individual genomes. SNP calling is a relatively
straightforward problem in analysis of sequencing data of individual genomes, because the
frequency of a candidate allele can be only 0 (non-variant), 0.5 (heterozygous) or 1
(alternate homozygous) for a diploid genome. Despite (high) sequencing error of NGS, a
reliable call can be easily made given a high depth of coverage, say 20X to 30X.
Consequently, statistical models for SNP calling have been developed and integrated as
one simple functional module in many NGS short reads analysis tools such as SAMtools
(Li, et al., 2009) , MAQ (Li, et al., 2008) and VarScan (Koboldt, et al., 2009). SAMtools
and MAQ use a Bayesian statistical model to compute the posterior probabilities of the
three possible genotypes. Specifically, for the likelihood part, they employ a binomial
distribution to characterize sampling of the two haplotypes, and the prior probability, like
other Bayesian approaches, is pre-specified. SAMtools and MAQ empirically set the prior
probability of observing a heterozygote to be 0.001 for the discovery of new SNPs, and 0.2
for inferring genotypes at known SNP sites. Such Bayesian approaches may not be ideal
for multiplicity control because of the subjectivity of assigning the prior probability.
VarScan implements a heuristic/statistical method. For each candidate site, it applies
several heuristic filters such as having a minimum number of supporting reads and allele
frequency reaching a minimum threshold. It also conducts a Fisher's exact test for testing
the deviation of the read counts supporting variant alleles from being generated because of
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sequencing error. Those heuristic filters overlap with the Fisher’s exact test in terms of
reducing false positives. When not systematically considered, they may distort the
statistics distribution under null and thus void the resultant p values for multiplicity
control.
Identifying SNPs from pooled NGS data is more challenging in that pooled DNA
are sampled from a number of individuals, which consequently will give rise to variant
allele frequencies other than simply 0, 0.5 or 1. Driven by the need for analysis of
increasing amount of pooled NGS data, several programs/methods for the detection of
variants from the pooled data have been developed. SNPSeeker employs the large
deviation theory for SNP detection (Druley, et al., 2009). It compares observed allele
frequencies against the distribution of sequencing errors as measured by the Kullback
Leibler (KL) distance (Kullback and Leibler, 1951). One limitation of this approach is that
its error model has to be estimated from negative control data. SNPSeeker was recently
extended to SPLINTER with two main improvements (Vallania, et al., 2010). First, it is
capable of detecting rare short indels. Second, it provides a good cutoff after ranking all
candidate variants to balance power and type I error rate, which, however, requires an
additional positive control data. CRISP (Bansal, 2010) models the number of reads of the
reference and alternate alleles at a particular position across all pools as a contingency
table, which is then tested by the Fisher’s exact test. Its working hypothesis is that, due to
rareness, presence of rare variants in all pools will be sporadic and then results in an excess
of reads with the alternate allele as compared with the other pools, which is expected to be
captured by the Fisher’s exact test. CRISP then conducts a complementary test for the
overabundance of alternate alleles within each pool against the sequencing error rate.
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Although it is shown that CRISP outperforms SNPSeeker, MAQ, and VarScan (Bansal,
2010), it has the following limitations. First, its working hypothesis does not hold well for
common variants. When the minor allele frequency is large and/or the number of
individuals in each pool is large, sporadic presence will disappear and result in no
prominent excess of reads that can be captured by the Fisher’s exact test. Second, their
method is not applicable for single pool data. Third, rareness and overabundance of
alternate alleles are related but are captured separately using two different models, which
may not be an efficient approach. In addition, these two separate tests make it hard to
obtain an overall multiplicity control. Finally, its computational efficiency makes
scalability an issue and may prevent its application in analysis of whole-exome or genome
sequencing data. The main bottleneck comes from computing the p-value of a large
number of contingency tables in the Fisher’s exact test.
In addition to the above direct SNP calling programs, there are also other relevant
studies for analysis of pooled NGS data, including estimating allele frequencies from
pooled sequencing (Ingman and Gyllensten, 2009), evaluating the ability to detect rare
SNPs (Out, et al., 2009), and investigating the power of variant detection in pooled DNA
for NGS and the optimal pooling designs (Lee, et al., 2011), among others.

2.2 Association Studies for Rare Variants
The limitations of genome-wide association (GWA) studies that focus on the phenotypic
influence of common genetic variants have motivated human geneticists to consider the
contribution of rare variants to phenotypic expression. Recent advances in next-generation
sequencing (NGS) technology have made it technically and economically feasible to
capture the full spectrum of genomic variation. NGS provides a powerful tool for
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systematic exploration of common and rare variants in the entire genome, even in large
population-scale studies (1000 Genomes Project Consortium, 2010). However,
pinpointing causal variants remains a major challenge, particularly for associating rare
variants with complex traits (Cooper and Shendure, 2011).
An illustration of scenarios in DNA-Seq studies in Figure 2.1, where the blue lines
indicate genomic regions and red boxes indicate variants. A) Variants at a single locus with
common alleles are more frequent in cases then controls. B) Multiple rare variations
contribute to the phenotype such that the collective frequency of these variations is greater
in cases. This would create a greater diversity of haplotypes or DNA sequences among the
cases. C) Multiple rare variations contribute to the phenotype but act in a synergistic
fashion, such that cases are likely to have more similar DNA sequences compared to
controls. D) Multiple rare variations contribute to a phenotype but the variations
contributing to the phenotype reside in specific genomic regions. This situation would
create greater sequence diversity among the cases, as in part b, but only in the relevant
genomic regions.
There is a substantial need for computational methods that allow for efficient
association analysis of rare variants. Several powerful approaches tailored for rare-variant
association studies have been proposed recently (Daye, et al., 2012; Li and Leal, 2008;
Neale, et al., 2011; Wu, et al., 2011). Although these tests offer the powerful tool to
investigate rare variants in the entire genome, resulted from the increasing availability of
high-throughput sequencing technologies, these methods may not be sufficient for their
success as appropriate analytical methods are also needed (Bansal, et al., 2010).
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Figure 2.1 Scenarios in which DNA sequence variants distinguish cases and controls.
Source: (Bansal, et al., 2010)

2.3 Identification of 3’UTR Switching from RNA-Seq
For transcriptome study, the introduction of RNA-Seq technology along with new analytic
methods makes it possible to address an increasing number of compelling biological
questions that may not be possible using microarray technology. In particular, alternative
RNA splicing and processing, common phenomena in eukaryotes, play so critical a role in

13

gene function regulation that they receive much attention in RNA-Seq analysis (Keren, et
al., 2010) and motivate quite a few methodological developments. For example, MISO
employs a probabilistic mixture model to quantify alternative splicing and processing, then
test the equality of transcript isoform ratios between samples (Katz, et al., 2010); MATS by
using a Bayesian statistical framework offers the flexibility to identify differential
alternative splicing and processing events that match a given user-defined pattern (Shen, et
al., 2012); DEXSeq employs generalized linear models to test for differential usage of
exons and provides reliable control of false discoveries by taking biological variation into
account (Anders, et al., 2012); other developments include (Griffith, et al., 2010; Rogers, et
al., 2012; Trapnell, et al., 2013). Despite the success of these methods, detecting 3’
untranslated regions (3’UTR) switching remains challenging. Very few, if any, methods
and tools are available for directly analyzing this special alternative RNA processing event.
3’ end processing plays a crucial role in eukaryotic mRNA maturation (Colgan and
Manley, 1997). Through cis elements in the 3’ translated regions (3’UTR) of mRNAs,
post-transcriptional gene regulation frequently occurs and determines the stability,
localization and translation of mRNA (Martin and Ephrussi, 2009; Moore, 2005). These
roles are mediated by interactions with RNA-binding proteins (RBPs) and microRNAs
(miRNAs) (Licatalosi and Darnell, 2010). Over half of mammalian genes contain
alternative cleavage and polyadenylation sites, which lead to various mRNA isoforms
differing in their 3’UTRs (Zhang, et al., 2005). The analysis of alternative cleavage and
polyadenylation in 3’UTR, including shortening and lengthening, has recently been
appreciated as a global phenomenon under different cell conditions (Flavell, et al., 2008; Ji,
et al., 2009; Mayr and Bartel, 2009; Sandberg, et al., 2008) and different species

14

(Sherstnev, et al., 2012; Smibert, et al., 2012; Ulitsky, et al., 2012). And this phenomenon
has received particular attention in cancer studies (Fu, et al., 2011; Lembo, et al., 2012;
Lin, et al., 2012; Mayr and Bartel, 2009).
In contrast with the increasingly recognized importance of APA, computational
methods and tools for the APA analysis using RNA-Seq are underdeveloped. In unraveling
APA regulation, Ji and colleagues scored relative expressions by taking the ratio of short
reads density in extended and common regions, as defined by distal and proximal PolyA
sites, respectively (Ji, et al., 2011). A higher score, therefore, indicated higher abundance
of long 3’UTR isoform. A similar approach was taken in a recent tandem 3’UTR analysis,
where the statistical significance was assessed by Fisher’s exact test for the switch-score
under different conditions (Wang, et al., 2008). The same group further improved the
approach and implemented a new computational tool, MISO (Katz, et al., 2010).
Specifically, tandem 3’UTR was treated as special alternative processing, and thus the
quantification of expression level for each isoform can be estimated by computing PSI
(Percent Spliced Isoform). These existing methods, however, have one critical drawback;
namely, they rely on prior knowledge of annotated PolyA sites. For example, MISO
constructs 3’UTR isoform based on PolyA sites information collected from the PolyA site
database (Lee, et al., 2007; Zhang, et al., 2005). It is noted that the PolyA sites from the
current database are computationally inferred from cDNA/EST sequences. It is far from
complete and may also contain false positives. Therefore, these approaches that depend on
PolyA information may not be precise or powerful due to incomplete information of all
potential cleavage sites on 3’UTR.
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This motivates the analysis of 3’UTR switching without relying on any PolyA
annotations, one major limitation of existing methods. In addition, existing tools also have
the same limitations, such as not capable of handling sample replicates, not supporting
multiple isoforms and no confidence interval estimates for the change-point. These
limitations warrant development of new bioinformatics methods.
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CHAPTER 3
SNVER: A STATISTICAL TOOL FOR VARIANT CALLING

3.1 Introduction
This chapter proposes a statistical tool, SNVer (Single Nucleotide Variant caller/seeker),
for calling common and rare variants in analysis of pooled or individual next-generation
sequencing (NGS) data. It formulates variant calling as a hypothesis testing problem and
employs a binomial-binomial model to test the significance of observed allele frequency
against sequencing error. SNVer reports one single overall p-value for evaluating the
significance of a candidate locus being a variant, based on which multiplicity control can
be obtained. This is particularly desirable because tens of thousands loci are
simultaneously examined in typical NGS experiments. Each user can choose the false
positive error rate threshold he or she considers appropriate, instead of just the
dichotomous decisions of whether to “accept or reject the candidates” provided by most
existing methods. Both simulated data and real data demonstrate the superior performance
of the program in comparison with existing methods. SNVer runs very fast and can
complete testing 300K loci within an hour. This excellent scalability makes it feasible for
analysis of whole-exome sequencing data, or even whole-genome sequencing data using
high performance computing cluster.
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3.2 Methods

3.2.1 Statistical Models for Single Pool Data
For a genomic locus, let θ be its minor allele frequency (MAF) in a population. If θ is larger
than a threshold θ0 (θ > θ0), then it is a single nucleotide polymorphism (SNP). Suppose
that sample N individuals (haploids) from this population for pooled sequencing. It can be
assumed that the number of individuals (n) carrying the minor allele follows a binomial
distribution b(N, θ), namely,

(

)

( )

(

with
(

)

)

Re-sequence this genomic region and suppose that K short reads cover this locus. If
no sequencing error, given n individuals carrying the minor allele, the number of minor
alleles X that observed from the K short sequence reads follows also a binomial distribution
b(K, n/N), namely,

(

)
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(

)

( )( ) (
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)

Now assume sequencing error rate to be , under which the minor allele will be
flipped to one of the other three alternate alleles, and vice versa. So the observed X follows
(

a binomial distribution (

)

), namely,
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Since n is not observable, sum it out and obtain the statistical model for X as
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Now consider the hypothesis test of whether this locus is a (rare) variant (θ > θ0)

Its significance p value will be
(

)

(
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)

3.2.2 Partial Conjunction Test for Multiple Pool Data
The above statistical model is for testing a locus in one single pool data. If M pools, the test
is performed in each pool separately. Therefore a set of M hypotheses for each candidate
variant can be obtained. The problem of making a variant call at one specific locus involves
the simultaneous testing of hypotheses at the set level. Typical questions considered in the
multiple-testing framework include: (i) Are all M hypotheses in the set true? (ii) Are all M
hypotheses in the set false? (iii) Are at least u out of M hypotheses in the set false? These
questions are referred to as conjunction test, disjunction test and partial conjunction test,
respectively (Benjamini and Heller, 2008). Testing whether a locus is a variant based on
multiple pool data is equivalent to the partial conjunction test that at least u =1 out of the M
hypotheses for that locus is false. Let

( )

( )

( )

be the ordered p-values obtained

from each single pool test. Following (Benjamini and Heller, 2008), the Simes method is
employed to calculate the pooled p-value for the partial conjunction test as

{

( )

}

If the set of M null p-values at the tested locus are independent, Benjamini and
Heller show that p1/M is a valid p-value for testing the partial conjunction null (Benjamini
and Heller, 2008). The Benjamini Hochberg (BH) procedure (Benjamini and Hochberg,
1995) and other multiple-test adjustments can then be applied to the pooled Simes’
p-values for multiplicity control when testing a large number of loci. It has been shown that
this Simes-BH procedure controls the false discovery rate (FDR) at the pre-specified
nominal level (Benjamini and Heller, 2008).
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3.3 Data Sets

3.3.1 Simulated Data
This section simulates synthetic data to investigate the numerical performances of the
proposed approach. For the single pool scenario, a total of 10,000 datasets are generated
under each combination of several conditions:


Sequencing coverage: low (10X) and high (30X)



Sequencing error: low (0.01) and high (0.05)



Minor allele frequency (MAF): rare variants with θ ~ U(0.001, 0.01), less common
variants with θ ~ U(0.01, 0.05), and very common variants θ ~ U(0.05, 0.5)



The number of sequenced individuals from low to high with N = 10, 20, 50, 100,
200, 500, 1000, 1500, 2000
For each MAF setting θ ~ U(θmin, θmax), the power of the proposed approach is

computed for detecting variants by testing the null hypothesis H0: θ < θmin. Meanwhile, it is
demonstrated that type I error is controlled at the nominal level by the proposed test, by
simulating θ ~ U(0, θmin) and evaluating how likely the same null hypothesis H0: θ < θmin
will be rejected by mistake. For both power and type I error evaluations, a variant is called
at the nominal level 0.05.
For the multiple-pool scenario, the simulation follows the above single pool
simulation settings except that simulates five pools with the same number of individuals in
each pool and the total N = 10, 20, 50, 100, 200, 500, 1000, 1500, 2000.

3.3.2 Real Data
This section assesses the performance of the proposed method in analysis of two pooled
and one individual real NGS datasets as summarized in Table 3.1. The first one is an
in-house Autism dataset generated using ABI SOLiD platform from sequencing three
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genomic regions, denoted as Core, CDH9 and CDH10, of size 187Kb, 158Kb and 158Kb,
respectively, on chromosome 5 of the human genome. 24 pools with six individuals in each
were made, totaling 144 samples. There are 12 pools for Autism case samples and the other
half 12 pools for control samples. One case pool experiment failed and therefore 23 pools
left in total for analysis. Short sequence reads were aligned by the Bioscope software from
ABI SOLiD with default parameters. The mapped short sequence reads covered >96% of
the three target regions with average 90X depth of coverage per individual. Meanwhile,
individual genotyping data was collected for each sample, which were generated from
Illumina HumanHap550v3 SNP arrays with ~550,000 markers. With individual
genotyping data, the concordance of identified variants was calculated between pooled
sequencing data and individual genotyping data for evaluating variant call quality.

Table 3.1 Summary of T1D and Autism Pooled Sequencing and ADHD Individual
Sequencing Datasets
Disease

Platform

Total
Reads

Reads
Length

#Pool

#Individual

Case

Ctrl

per pool

Region

Coverage
per
individual

Autism

SOLiD

~402M

50bp

11

12

6

~502 Kb ~90X

T1D

454

~9.4M

~250bp

10

10

48

~31 Kb

~80X

ADHD

Illumina

~57M

76bp x 2

3 individuals

~38 Mb

~20X

The second dataset was collected in a recent study of causative Type 1 Diabetes
(T1D) variants (Nejentsev, et al., 2009). Exons and splice sites of 10 candidate genes were
resequenced by the 454 sequencing system. Ten pooled samples each comprising equal
amounts of DNA from 48 T1D patients and ten pooled samples each comprising equal
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amounts of DNA from 48 healthy controls were made, totaling 480 T1D patients and 480
healthy controls from Great Britain. For each of the 20 pooled DNA samples, the numbers
of produced short reads range from 281,270 to 579,102, with average length of 250 bases
and 9,416,365 reads in total. These reads were mapped by BWA-SW (Li and Durbin,
2010) with default parameters and the average depth of coverage is 80X per individual.
The third one was an in-house individual sequencing dataset. Paired-end exome
sequencing was performed on three members affected with attention deficit/hyperactivity
disorder (ADHD) in a pedigree, using the Illumina Genome Analyzer IIx platform with
read lengths of 76 base pairs. It targets all human exonic regions totaling approximately 38
Mb. The short reads were aligned by BWA with default parameters and removed
duplicates by PICARD (http://sourceforge.net/projects/picard/). These mapped and
cleaned short reads were then re-aligned locally by the GATK IndelRealigner tool
(DePristo, et al., 2011). The average depth of coverage is about 20X for each patient.
Meanwhile, the genotyping data were collected of these three patients, generated from the
Illumina Human610-Quad version 1 SNP arrays with ~610,000 markers (including
~20,000 non-polymorphic markers).
For pooled sequencing data, CRISP has been shown to outperform other existing
methods (Bansal, 2010), the comparison between SNVer and CRISP was performed for
evaluation. SAMtools was also included for comparison although it was not designed for
pooled sequencing data. For the ADHD individual data, SNVer was compared with
SAMtools and GATK. Variant positions were called and filtered by SAMtools with all
default settings plus using awk ‘($3 = = “*” &$6> = 50) || ($3! =“*” &$6> = 20) ’, as
suggested by the SAMtools website. For the ADHD data, SAMtools with the suggested
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setting returned so many variants that SAMtools results were reported with an additional
filtering -d20 to remove variant calls with sequencing coverage less than 20, for getting
comparable numbers of variant calls as SNVer. Variants were also called using the GATK
UnifiedGenotyper, followed by further filtering based on the latest recommendations from
the GATK. CRISP has its own pileup procedure integrated in its analysis pipeline. To
make a fair comparison, following CRISP (Bansal, 2010) similar quality control was
performed and set the same processing parameters such as mapping quality and base
quality filtering thresholds.

3.4 Results

3.4.1 Power and Type I Error Evaluations
The single pool results are shown in Figure 3.1. It can be seen that the proposed method can
control type I error rate at the nominal level 0.05 in all settings. The number of sampled
individuals (sample size) and the depth of coverage are both shown to be helpful in
improving power. The largest improvement of ~10% attributed to depth of coverage (from
10X to 30X) is observed in the rare variants and high sequencing error (up-right panel).
The improvement contributed by larger sample size keeps increasing at a decreasing rate
until saturated. These power improvement curves would be helpful for pooling experiment
design and provide guidance as to how to balance sample size (cost) and desired power. As
expected, rare variants are much harder to be detected than common variants. A large
sample is required for achieving high power to detect them. Finally, higher sequencing
error (0.05 vs 0.01) puts a small dent to power.
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Figure 3.1 Power (PW) and Type I error rate (Err) of SNVer using single pool data at low
(10X) and high (30X) coverage.
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Figure 3.2 Power (PW) and Type I error rate (Err) of SNVer using multiple pool data at
low (10X) and high (30X) coverage.
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Figure 3.2 shows similar results for the multiple-pool scenario. Again, type I error
rate is controlled at the nominal level 0.05. It is also observed that given the same number
of sequenced individuals, single pool design yields a bit higher power with lower type I
error rate in comparison with multiple pool design, for example, 1000 individuals using
one single pool vs five pools with 200 individuals in each. CRISP selects candidate SNPs
by the Fisher’s exact test, which is then followed by additional filtering steps. In the
multiple-pool scenario, it is shown that the rankings of candidates SNPs by the proposed
test is superior to those by the Fisher’s exact test employed by CRISP. To compare the
efficiencies of these two rankings, the 10,000 positives with θ ~ U(θmin, θmax) and 10,000
negatives with θ ~ U(0, θmin) are divided into 100 groups, each with 100 positives and 100
negatives. These 200 loci are then ranked by their significance levels of testing the null H0:
θ < θmin using the statistical models. Rankings based the Fisher’s exact test are also
generated. The area under the curve (AUC) score averaged over 100 groups is used to
evaluate these two rankings as shown in Figure 3.3 for the typical scenario of 30X
coverage and 0.05 sequencing error. It can be seen that the Fisher’s exact test is very
inefficient for detecting common and less common variants. CRISP therefore has to rely on
additional sequencing error models to complement the Fisher’s exact test for detecting
common variants. The BH procedure is applied to control FDR at the nominal level of 0.1
and 0.05. The number of sequenced individuals is modeled in the test and is shown to be
helpful. This information is not explicitly utilized by CRISP in its Fisher’s exact test and
therefore contributes very little for detecting common and less common variants, although
CRISP models it at the later filtering step.
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Figure 3.3 Ranking efficiency of the binomial models employed by SNVer vs the Fisher’s
exact test employed by CRISP.
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Figure 3.4 Correlation between the minor allele frequencies and its estimates in pooled
sequencing.

The accuracy of allele frequency estimation has an impact on variant call, and is
more critical for establishing association in genetics studies. Therefore the estimated minor

29

allele frequency (MAF) against the actual MAF when  = 0.01 is plotted in Figure 3.4. For
a moderate sample size of 250,

good concordance are observed with correlation

coefficients r2=0.9828 and r2=0.9318 for the single-pool design and the multiple-pool
design, respectively. When the sample size increases to 1000, the concordance improves to
r2=0.9955 and r2=0.9769 for the single-pool design and the multiple-pool design,
respectively. The lower concordance of the multiple-design may be attributed to its
additional between-pool variance. It also explains why single pool analysis yields fewer
false positives than the multiple pools design for the same set of samples.

3.4.2 Better Performance
The user of SNVer only needs to set the sequencing error rate  and the variant threshold
θ0. SNVer will then report the significance p values of the tested loci of how likely their
MAF θ < θ0. Assume  = 0.01 for all real datasets. CRISP calls both rare and common
variants, so θ0=0 is set for SNVer to compare their performance in calling variants. CRISP
will output the variants it calls, while SNVer will report overall significance p values for
each locus, based on which the user can choose a threshold he/she feels appropriate and
make variant calls. To make a comparison, loci are ranked by their p values output by
SNVer and the significance threshold is taken that gives the same number of variants called
by CRISP. The loci identified as variants by these two programs are then annotated by
SeattleSeq (http://gvs.gs.washington.edu/SeattleSeqAnnotation/), and count how many of
them have been confirmed as variants in dbSNP. Following (DePristo, et al., 2011), variant
call quality is evaluated by examining dbSNP rate, transition/transversion (Ti/Tv) ratio and
concordance of sequencing and individual genotyping calls. A higher Ti/Tv ratio generally
indicates a higher accuracy; this metrics is particularly helpful for assessing novel single
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nucleotide variant calls (DePristo, et al., 2011). The variant call results are summarized in
Table 3.2. For the Autism and T1D pooled sequencing datasets, SNVer has the higher
dbSNP rates, the higher overall Ti/Tv ratios, and the higher Ti/Tv ratios for new sites, in
comparison with CRISP. It indicates the better quality of the call sets SNVer produced. In
contrast, SAMtools made much fewer SNP calls which led to much lower sensitivities,
despite its higher Ti/Tv ratios. Out of the 110 SNPs that have been genotyped by SNP
arrays in the Autism dataset, SAMtools identified only 16 SNPs with 100% genotyping
concordance, while both SNVer and CRISP called about 100 SNPs with 100% genotyping
concordance. This confirms that SAMtools may not be appropriate for pooled sequencing
data. The correlation between alternate allele frequencies in individually genotyped DNA
samples and frequency estimates in the sequenced DNA pools is plotted in Figure 3.5, with
r2=0.92 and r2=0.94 for the Autism case and control, respectively. The achieved 100%
genotype concordance with less perfect frequency estimates is not surprising because
accurate estimate of allele frequency θ is only critical for rare variants when testing θ>0.
As shown in Table 3.2 , for the ADHD individual sequencing data, under
family-wise error rate 0.05 level, SNVer also obtained the variant call sets with good
quality. This is evidenced by the ~97% dbSNP rates, the ~2.9 overall Ti/Tv ratios, the 2.22
to 2.73 Ti/Tv ratios for novel sites, and the 99% genotype concordance. SAMtools with
suggested parameters/filters made 2+ times more variant calls than SNVer (e.g. ~49K vs
~18K). The lower Ti/Tv ratios and genotype concordance suggest poorer quality for these
larger call sets made by SAMtools. When applied with an additional filtering of
sequencing depth >=20X, SAMtools identified fewer SNPs than SNVer. But it still has
lower quality as indicated by the lower Ti/Tv ratios and genotype concordance. Compared
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with GATK, SNVer has similar performance, while with the higher Ti/Tv ratios for novel
variants in all three individuals.

Method
CRISP
SNVer
SAMtools
CRISP
SNVer
SAMtools
CRISP
SNVer
SAMtools
CRISP
SNVer
SAMtools
SNVer
SAMtools
SAMtools20X
GATK
SNVer
SAMtools
SAMtools20X
GATK
SNVer
SAMtools
SAMtools20X
GATK

92157

ADHD (Individual)
84615
84060

T1D (Pooled)
Control
Case

Data
Autism (Pooled)
Control
Case

Table 3.2 Comparison of SNP Calling by CRISP, SAMtools, GATK and SNVer
No. of SNP
All Known Novel dbSNP%
2182 1791 391
82.1
2182 1795 387
82.3
261 260
1
99.6
2063 1610 453
78.0
2063 1617 446
78.4
239 238
1
99.6
306
93
213
30.3
306 126 180
41.2
14
9
5
64.3
167 110
57
65.9
167 120
47
71.9
18
12
6
66.7
18001 17535 466
97.4
48988 47513 1475 97.0
15038 14538 500
96.7
19655 19713 482
97.6
17436 16914 522
97.0
46037 44489 1548 96.6
15510 14942 568
96.3
18892 18419 473
97.5
18676 18208 468
97.5
49729 47693 2036 95.9
15881 15370 511
96.8
20100 19631 469
97.7

Ti/Tv&
All Known Novel
1.68 1.79 1.26
1.71 1.81 1.35
2.26 2.29 0/1
1.68 1.83 1.27
1.78 1.89 1.45
2.06 2.05 1/0
0.95 2.58 0.63
1.71 2.15 1.47
10/4 8/1
2/3
1.49 2.93 0.46
2.34 3.00 1.35
14/4 11/1 3/3
2.89 2.89 2.73
2.66 2.68 2.16
2.70 2.72 2.11
2.91 2.94 2.15
2.85 2.87 2.22
2.64 2.67 1.94
2.74 2.77 2.02
2.89 2.92 2.03
2.90 2.92 2.37
2.69 2.73 2.03
2.80 2.83 1.99
2.98 3.00 2.35

Concord.+
TP/P (%)
101/101 (100%)
102/102 (100%)
16/16 (100%)
96/96 (100%)
95/95 (100%)
16/16 (100%)

N/A

4158/4183 (99%)
4437/8116 (55%)
2034/3158 (64%)
4649/4657(100%)
4032/4063 (99%)
4173/7643 (54%)
2062/3247 (64%)
4537/4566(99%)
4192/4224 (99%)
4251/7996 (53%)
2028/3259 (62%)
4700/4710(100%)

&: Transition and transversion ratio for the identified variants. When the number of variants is small it just
reports the numbers but not calculate the ratio, e.g., 10/4 for all variants in T1D case by SAMtools means 10
transitions and 4 transversions.
+: genotype concordance. P represents the number of variants called by each program and also genotyped. TP
represents the number of variant calls concordant between sequencing data and individual genotyping data.
20X: Additional filtering of sequencing depth >=20 is applied.

It is noted that the Ti/Tv ratios for the pooled sequencing data are low for both
programs. This suggests that they may not perform well if estimating the false positive
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rates using the Ti/Tv ratios (DePristo, et al., 2011) and confirms that variant calling is more
challenging for pooled sequencing. Meanwhile, estimating false positive rates using this
summary statistic should be cautious for pooled sequencing. First, Ti/Tv estimate for
pooled samples is not as accurate as for individual samples. Second, targeted resequencing
regions are usually small, e.g., 31 Kb for the T1D data and 500Kb for the Autism data, and
therefore will exhibit higher genomic and statistical variances. For example, the ADHD
individual 84060 has an exome-wide Ti/Tv ratio of 2.89 for all variants; if calculating
Ti/Tv ratios based on only 500Kb regions, then the smallest Ti/Tv ratio obtained is 1.31,
and the largest 7.00 with SD=1.53 (consider only 500Kb regions with at least 30 variants
for having stable Ti/Tv ratio estimates).

Figure 3.5 Correlation between alternate allele frequencies in individually genotyped
DNA samples and its estimates in the sequenced DNA pools for the Autism dataset.
Different symbols represent different depth of coverage ranges as shown in the legend.
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3.4.3 Better Scalability
SNVer and SAMtools exhibit similar efficiency in terms of running time. The running time
of SNVer and CRISP in analysis of the T1D and Autism datasets is given in Figure 3.6.
The main bottleneck of CRISP comes from computing the p-value of a large number of
contingency tables in the Fisher’s exact test. Therefore, in additional to the number of tests,
its time efficiency is also largely dependent on the number of pools and the depth of
coverage. In contrast, these two factors have little impact on SNVer and its running time is
roughly linear with the region size (the number of tests). For example, SNVer spends 0.1 hr
on 31Kb and 1.5 hr on 502Kb for the two datasets, respectively. SNVer is much faster than
CRISP. Taking the T1D case for example, SNVer is about 500-fold faster than CRISP and
achieves 300Kb/hr. Such efficiency makes feasible the application of SNVer to analysis of
whole-exome sequencing data, or even whole-genome sequencing data using high
performance computing cluster, both of which, however, will take prohibitively longer
time for CRISP.

Figure 3.6 Comparison of running time of SNVer and CRISP for testing the T1D ~30Kb
region and the Autism ~500Kb region. Running time of SNVer is mainly determined by
the region size (the number of tests), while larger pool numbers and sequencing depth will
take additional time for CRISP.
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3.4.4 Informative Ranking and Multiplicity Control
SNVer reports one single overall significance p-value for each locus, based on which the
rankings of all tested loci can be produced. Such rankings are more informative and
accurate than the dichotomous decision of whether to “accept or reject the candidate as a
variant” provided by CRISP and most other existing methods. For example, four rare
variants have been found to be associated with T1D based on the T1D dataset by
comparing the estimated MAF in cases and controls (Nejentsev, et al., 2009). If use SNVer
to call these four variants by testing the null hypothesis

=0.01, the rankings of them

by SNVer can be obained in Table 3.3, as well as the dichotomous decisions made by
CRISP. For SNVer, very significant ranking changes of these four SNPs can be observed,
which are consistent with their MAFs (relative to the threshold 0.01) and the MAF
differences. CRISP identifies three of them, rs35337543, ss107794688 and ss107794687,
as variants in both cases and controls, exhibiting no informative differential changes. It
should be noted that the ranking difference may only reflect frequency difference. Large
frequency difference between case and control of those variants may suggest their potential
association with the phenotype, but their functional importance to the phenotype is yet to
be assessed by further experiments.
In addition to ranking, valid p values given by SNVer also make multiplicity
control possible. Tens of thousands or millions loci are usually simultaneously examined
in typical NGS experiments. It is particularly desirable to have multiplicity control, which
gives the user an idea of the chance of making any errors and/or the proportion of false
positives among the variant calls they make. Each user can choose the type I error rate
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threshold he or she considers appropriate, instead of just the dichotomous decisions of
whether to “accept or reject the candidates” provided by most existing methods.

Table 3.3 Informative Rankings of Four Rare Variants with the Null Hypothesis
=0.01
T1D Case
SNP

T1D Control

Estimated
MAF

SNVer
Ranking

CRISP
CALL

Estimated
MAF

SNVer
Ranking

CRISP
CALL

rs35337543

0.36%

17557

Y

2.51%

45

Y

rs35667974

0.72%

17557

N

2.42%

59

Y

ss107794688

0.50%

17557

Y

1.79%

56

Y

ss107794687

1.07%

145

Y

2.45%

51

Y

3.5 Conclusion and Discussion
This chapter has developed a novel statistical tool SNVer for calling SNPs in analysis of
pooled NGS data. Different from the previous models employed by CRISP, it analyzes
common and rare variants in one integrated model, which considers and models all
relevant factors including variant distribution and sequencing errors simultaneously. As a
result, the user does not need to specify several filter cutoffs as required by CRISP. Some
variant calling methods simply discard loci with low depth of coverage to achieve reliable
variant calls. The statistical model does not discriminate against poorly covered loci. Loci
with any (low) coverage can be tested and depth of coverage will be quantitatively factored
into the final significance calculation. SNVer reports one single overall significance
p-value for evaluating the significance of a candidate being a variant. An advantage of
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reporting results on a more continuous scale, instead of just the dichotomous decision of
whether to “accept or reject the candidate as a variant” as most existing methods do, is that
the user can choose the alpha threshold he or she considers appropriate. In this chapter,
both simulated data and real data are used to demonstrate the superior performance of the
program in comparison with pre-existing methods. Although SNVer is motivated by the
need for analysis of pooled NGS data, it can also be applied to individual NGS data as a
special case (N=2 for diploid species), as shown in the ADHD dataset.
The current program can be improved and extended in several ways. First, small
indels are not supported. Indels impose a great challenge for NGS including DNA
amplification and reads mapping which are under fast development. When those
techniques become mature in handling indels, it is worth investigation of their distribution
and work out a proper calling strategy. Second, sequencing quality scores can be utilized to
estimate site-specific sequencing error. Third, the majority loci of sequenced segments are
known to carry no variants. The density of SNP is estimated to be around 1 out of 1000
bases. Such prior percentage of non-nulls information may help obtain more precise
multiplicity control. Fourth, the dependency among tests will also be informative in
increasing testing efficiency. It has shown that the LD dependency information is very
informative in increasing the efficiency of conducting genome-wide association tests in
analysis of GWAS data (Wei, et al., 2009). It is also found recently that dependency
information is helpful for increasing the efficiency of testing hypotheses at the set level
(Sun and Wei, 2011). For NGS data, one non-null (variant) is expected from every 1000
consecutive genomic bases. Such dependency patterns, if appropriately modeled, may help
further improve testing efficiency. Finally, the current program focuses on calling variants,
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namely, testing whether θ is larger than a threshold. Under the same framework, the
models can be naturally extended for case-control association studies by testing whether
θcase= θcontrol.
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CHAPTER 4
SNVERGUI: A DESKTOP TOOL FOR VARIANT ANALYSIS

4.1 Introduction
Advances in next-generation sequencing (NGS) technology have made it possible to
comprehensively interrogate genome-wide genetic variations. However, most existing
tools for variation detection are based on command-line interface, which discourages the
main end users of NGS data, such as biologists, geneticists and clinicians, from utilizing
the software. This chapter develops the SNVerGUI, a graphical user interface (GUI)-based
tool for variant detection and analysis. Compared with other methods for variant calling,
the proposed approach is unique in that it is applicable to both individual and pooled
sequencing data. With friendly GUI, end users can easily adjust running parameters to
optimize variant calling for their specific needs. SNVerGUI supports commonly used input
and output file formats that allows SNVerGUI to be seamlessly integrated into common
NGS data analysis pipelines. SNVerGUI is implemented in Java, which is
platform-independent and therefore easy to install and run on the commonly used
operating systems, such as Linux, Mac, and Windows.

4.2 Results
Most existing NGS variant calling tools (Bansal, 2010; DePristo, et al., 2011) provide only
command-line interfaces. Typically, users must execute these tools and sometimes apply
additional filters from the command line. This may discourage biologists, geneticists,
clinicians, and other end users who often lack the programming expertise to allow them to
easily apply non-GUI tools. Quite a few GUI-based variant calling softwares have been
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developed for addressing this concern (Bao, et al., 2009; Hou, et al., 2010; Qi, et al., 2010).
However, they are not adapted to detecting variants from pooled sequencing data, which
account for a sizable proportion of current NGS studies (Calvo, et al., 2010; Nejentsev, et
al., 2009; Out, et al., 2009). This is the motivation of the SNVerGUI, a graphical user
interface (GUI)-based desktop environment, in order to exploit the unique merits of the
recently developed statistical tool SNVer (Wei, et al., 2011) for detecting SNVs and indels
from both pooled and individual NGS data. The pipeline of SNVerGUI is illustrated in
Figure 4.1. Its new and key merits are highlighted as follows.

Figure 4.1. Pipeline of SNVerGUI. SNVerGUI employs PICARD-API and SAM-JDK for
processing alignments, and utilizes SNVerPool and SNVerIndividual for calling variants
(both SNV and indel) in analysis of pooled or individual NGS data.

First, compared with its previous command-line version (Wei, et al., 2011),
SNVerGUI adds three new features. 1) It can estimate locus-specific sequencing error from
data, and thus users don’t need to specify this critical parameter. 2) SNVerGUI can call
indel variants. 3) Variant outputs in VCF can be directed to the user-friendly web version
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of the popular annotation tool wANNOVAR (Chang and Wang, 2012) for delineating their
functional consequences.
Second, SNVerGUI is applicable to both individual and pooled NGS data by using
a unified binomial-binomial statistical model. It can handle single-pool NGS data, which
cannot be processed by most, if not all, existing state-of-the-art tools. Its computational
efficiency makes it feasible to analyze whole-exome or whole-genome NGS data.
Third, SNVerGUI supports widely used input and output file formats. SNVerGUI
accepts aligned read data and reference sequence data in popular file formats, such as
.fasta, .sam and .bam files. Variant detection results are outputted in the CSV format that
can be directly opened by Excel. They are also outputted in the standard VCF (Variant Call
Format) (Danecek, et al., 2011) that can be accepted by other powerful tools as input, e.g.,
VarSifter (Teer, et al., 2011) for filtering and ANNOVAR (Wang, et al., 2010) for
annotation.
Fourth, SNVerGUI provides flexible interactive post-call processing. Analysis
results are displayed in easy-to-analyze table views that support sorting variants by
p-value, sequencing depth, allele frequency, etc. Users can easily customize the output
according to their needs, based on their experience and/or desired multiplicity control by
setting different cutoffs.
Finally, SNVerGUI is platform-independent. As a Java-based software,
SNVerGUI inherits Java’s trademark property to allow to “write once, run anywhere”. The
program is wrapped in “one-click” easy-to-install package and runs on the commonly used
operating systems, such as Linux, Mac, and Windows.
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The superiority of the statistical model for variant detection, including accuracy,
sensitivity, and computational efficiency, has been extensively documented in (Wei, et al.,
2011). Table 4.1 briefly describes how to apply the GUI tool to analyze two real datasets in
order to illustrate the analysis pipeline. Specifically, one pooled targeted resequencing
Type 1 Diabetes (T1D) (Nejentsev, et al., 2009) dataset and one individual exome
sequencing attention deficit/hyperactivity disorder (ADHD) data (Lyon, et al., 2011) were
analyzed. The reads of the two datasets were mapped using BWA-SW(Li and Durbin,
2010) and BWA(Li and Durbin, 2009), respectively, with default parameters. Then
mapping results were outputted in BAM format.
The two data sets were tested on Windows 7 Professional 64-bit OS, with Intel(R)
Core(TM) i7 3.07GHz processor and 12.0 GB installed memory (RAM). The aligned
BAM files, together with target regions, reference genome, and dbSNP file, were specified
in SNVerGUI’s graphical user interface. Variant calling was then executed using default
parameters. It took SNVerGUI ~1.45h to analyze the T1D pooled data and ~1.75h to
analyze the ADHD individual data (Table 4.1). This efficiency demonstrates that
SNVerGUI is capable of analyzing high volume NGS data within very reasonable time.
Notably, the analyses were performed using a fixed memory of only 1GB, which shows
that SNVerGUI is so memory-efficient that it can be used as a desktop tool to analyze even
whole-genome NGS data. Moreover, one can increase the Java Virtual Machine heap size
by simply modifying the configuration file before launching SNVerGUI. The running time
for analyzing such data sets would be shortened with larger memory, which highlights the
flexibility of SNVerGUI in the aspect of memory management. Therefore, as a desktop
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tool, it is feasible to analyze a myriad of NGS data at different scales if enough memory
and CPU are provided.

Table 4.1 Summary and Performance on T1D Pooled Sequencing and ADHD Individual
Sequencing Data
Data

Platform

T1D
ADHD

454
Illumina

Total
reads
~4.9M
~19M

Read
Length
~250bp
76bp PE

#pool
10
-

Pool
Size
48
-

Target
Region
~31kb
~38Mb

Coverage

Time

~80X
~20X

~1.45h
~1.75h

4.3 Summary
In summary, this chapter has developed the SNVerGUI, a user-friendly desktop tool to call
variants for the analysis of pooled sequencing and individual sequencing data. Using this
software, users can perform sophisticated variant detection by simply configuring several
parameters in a friendly graphical user interface and annotate variants in wANNOVAR
(Chang and Wang, 2012) conveniently. Using two real datasets, it has been shown that
SNVerGUI tool is capable of analyzing very high volume NGS data in feasible time.
Hence, SNVerGUI is a fast and easy GUI tool for identification of genomic variants. As a
desktop tool, it has demonstrated the feasibility of conducting variant detection analysis on
personal computers. It makes bioinformatic analysis as simple and effortless as possible, as
needed for clinical genetics and personalized medicine. It should be expected its popularity
among geneticists, clinicians, and biologists, as well as small labs which cannot afford
costly bioinformatics personnel and infrastructure as is currently required for analyzing
NGS datasets (Sboner, et al., 2011). With the advent of desktop sequencers (Loman, et al.,
2012), such a desktop bioinformatics tool would become much demanded for NGS data
analysis.
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CHAPTER 5
COLLAPSING SINGLETONS FOR ASSOCIATION STUDY

5.1 Introduction
Advances in next-generation sequencing (NGS) technology have made it possible to
comprehensively interrogate the entire spectrum of genomic variations including rare
variants. They may help capture the remaining genetic heritability which has not been fully
explained by previous genome-wide association studies (GWAS). This chapter performs a
gene-based genome-wide scan to identify hypertension susceptibility loci in analysis of a
whole genome sequencing cohort of 103 unrelated individuals. It has found that collapsing
singletons may boost signals for associating rare variants and identified SETX statistically
significant by a genome-wide gene-based threshold (P value < 5.0×10-6). The function of
SETX in hypertension may be worthy of further investigation.

5.2 Data
The Genetic Analysis Workshop 18 (GAW18) provided a whole genome sequencing
dataset for a hypertension cohort of 483 individuals. These samples were sequenced by
Complete Genomics with ~60x coverage, and odd numbered autosomes data were made
available for analysis. After quality control, 464 individuals and 24 million SNPs
remained. Of those SNPs, over 51% had MAFs < 1%, which was the focus of the analysis
in this chapter. The longitudinal hypertension phenotypes were provided for up to four
time points. Since the analysis was focused on binary traits, it treated individuals diagnosed
with hypertension in any of the four times as cases. 103 genetically unrelated individuals
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were extracted with both phenotype data and sequencing data, where 39 unaffected
controls and 64 cases affected by hypertension were found.

5.3 Methods
The variants were stored in VCF files. The pre-processing includes the following. 1)
Filtered out SNPs that were present in dbSNP132 or MAFs > 1%, for getting rare variants.
2) Filtered out SNPs with genotype missing rate > 5%. 3) The remaining missing
genotypes were resampled from non-missing individuals. 4) Collapsed singletons, a
variant being observed only once among all the samples, as one indicator variable by

{

.

The rationale was that the distribution of singletons as a group may reflect the association
between target region and phenotype. 5) Grouped variants into sets based on RefSeq gene
annotations (Pruitt, et al.), requiring SNPs lie between the RefSeq transcript start site (TSS)
and transcript end site (TES). SNPs outside gene boundary were not analyzed. In total,
10,148 genes from odd numbered chromosomes were used.
This chapter employed three recently published rare association tests, qMSAT
(Daye, et al.), C-alpha (Neale, et al., 2011) and CMC (Li and Leal). The qMSAT was a
quality-weighted multivariate score association test that can utilize genotype quality
information. However, genotype quality score information was not available in the
GAW18 raw VCF files. Without utilizing quality information, the qMSAT test was
equivalent to the linear SKAT (Wu, et al.), SSU (Pan, 2009) and C-alpha. The C-alpha test
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compared the assumed binomial distribution of rare variants in cases versus controls via a
homogeneity test. CMC, a combined Multivariate and Collapsing Method, collapsed
variants in subgroups according to allele frequencies and combines these subgroups using
Hotelling's T2 test. For all these three tests, permutations were used to evaluate association
significance. Because permutation was computationally expensive, a two-step strategy in
searching and testing candidate loci was used. Specifically, it first used 1000 permutations,
from which it can identify candidates with estimated P value < 0.001. Then for these
candidates it conducted 106 permutations so as to know if any loci were significant at a
genome-wide gene-based threshold (0.05/10000=5.0×10-6) using a Bonferroni assumption.

Table 5.1 Genes with P < 0.001 from at Least One Method Using 103 Permutations
Chr

Gene

#Variants(Singletons)

qMSAT

chr1
chr1
chr7
chr9
chr9
chr11
chr11
chr19
chr19
chr19
chr5
chr15
chr17
chr17
chr1
chr7
chr19
chr5

NUP210L
USP1
CUL1
RAB14
SETX
FLJ39051
GDPD5
GRIN3B
LOC100505495
PSG5
CXXC5
RCCD1
WSCD1
MLLT6
ATF6
ZNF775
LOC100128252
LOC728342

674(221)
51(19)
348(114)
88(32)
380(135)
44(11)
338(104)
24(8)
249(78)
111(26)
96(35)
32(13)
183(70)
92(33)
576(173)
69(21)
45(13)
495(146)

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
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C-alpha

CMC

Y

Y

Y

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

5.4 Results
After the pre-processing step, it obtained ~2.2 million rare variants, which were assigned to
10148 genes for testing. Then the three tests were performed, qMAST, C-alpha and CMC,
using R (www.r-project.org). The qMSAT, C-alpha and CMC identified 10, 6 and 7 genes
with estimated P value < 0.001, respectively (Table 5.1). Only SETX revealed significance
for all of the three methods. Using 106 permutations, qMSAT, C-alpha and CMC yielded
more precise p-values of 2.0×10-6, 1.0×10-6, and 6.0×10-6, respectively, for SETX (Table
2). The CMC p-value was slightly higher than the genome-wide gene-based threshold,
which was possibly due to its lower power compared to qMSAT and C-alpha (Daye, et al.).
SETX locates in chr9:135,136,827-135,230,372 and is a relatively large gene
among all the human genes. The length of SETX (93,545bp) is far greater than the median
number (17,970bp) of all the genes (P-value<2.2×10-16, one-sided Wilcoxon signed rank
test). Although it contains 26 exons, the total length of coding regions is only 8,034,
suggesting that SETX includes large intronic regions. In order to pinpoint causal regions,
the 380 variants of SETX into three groups were divided based on its functional
annotations. Specifically, ANNOVAR was applied (Wang, et al.) to annotate the variants
of SETX and grouped them into coding sequence regions (CDS), untranslated regions
(UTR) and intronic regions (INTRON) (Table 5.2). It is observed that majority of rare
variants were, indeed, from intronic region. These three regions were tested using the same
tests with 106 permutations. The UTR group and the CDS group were far from being
significant, suggesting that they may be irrelevant. Another possible reason may be that
there are very few variants in these categories. Due to the fact that the INTRON group
became more significant than the whole gene-based tests after excluding the variants from
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these two groups, and therefore it may be concluded that causal variants were located in the
intronic region of SETX.
The next was to elucidate why and where the signal came from. To this end, several
in-depth analyses for SETX were performed. First, the Fisher’s Exact test was conducted
on the super feature created by collapsing singletons. It has been found that, by collapsing
all the 135 singletons on SETX, it achieved a very significant p-value (3.7×10-6), together
with OR=8.8 and 95% CI = [3.12, 27.43] (Table 5.2). This explained why SETX could be
detectable under such a small sample size. It obtained more significance when testing the
super feature with only singletons within the intronic regions (P-value=8.8×10-7, OR=9.5
and 95% CI=[3.43,28.70]), which was consistent with the results from three rare variant
association tests. Second, each rare variant and singleton were checked individually by
performing the same test. It turned out that none of them were significant, where the
minimum p-value was merely 0.14. This demonstrated that the significance of SETX was
very unlikely due to technical artifact, such as systematic sequencing error or imputation
bias, because the new feature was a combination of hundreds of singletons. It also
highlighted that collapsing singletons may increase power when studying association of
rare variants using a relatively small sample size. Third, a closer examination was took for
allele frequencies of the 380 rare variants located in SETX. 92 of them could be found in
1000 Genomes Project (2012 Feb release, http://www.1000genomes.org/). It can be seen
that their allele frequencies in general population were extremely low (mean
frequency=0.0004 for 92 rare variants), indicating that these variants were so rare that they
may collectively have a composite effect of OR=8.8 while missed in previous studies.
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Table 5.2 Functional Annotation and Test of the Rare Variants in SETX
P-value | OR | 95%CI
#Variants

Fisher’s Exact Test on

(Singletons)

Super Variant&

SETX
(GENE)

380(135)

3.7×10-6 8.8 [3.12,27.43]

CDS

14(8)

1.000

1.0

UTR

6(4)

0.632

0.6

INTRON

360(123)

Regions

P-value*
qMSAT

C-alpha

CMC

2.0×10-6

1.0×10-6

6.0×10-6

[0.18, 6.94]

1.000

0.544

0.837

[0.04, 8.60]

1.000

0.662

0.990

8.8×10-7 9.5 [3.43,28.70] <1.0×10-6 <1.0×10-6 <1.0×10-6

*: P-values were calculated using 106 permutations.
&: Super variant was defined by collapsing all the singletons.

Finally, to further remove possible cofounding effect of population stratification, a
principle component analysis (PCA) was performed on a set of randomly selected 100k
common variants with no missing value and MAF>0.1. Logistic regression test was then
conducted on the created super feature for SETX, together with the first ten principle
components as covariates. It can be found that the super feature remained significant with a
P-value=6.7×10-5 while the ten principle components were not.
The protein encoded by SETX contains a DNA/RNA helicase domain at its
C-terminal, suggesting its involvement in both DNA and RNA processing. Mutations in
SETX have been reported to be associated with ataxia-ocular apraxia-2 (AOA2) (Arning,
et al., 2008) and an autosomal dominant form of juvenile amyotrophic lateral sclerosis
(ALS4) (Chen, et al., 2004; Pruitt, et al.). However, the function of SETX and its role in
hypertension remains unclear and may be worthy of further investigation.
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5.5 Summary
This chapter performs three rare-variant association tests for the analysis of a whole
genome sequencing dataset to identify susceptibility genes in hypertension. It groups and
collapsed rare variants in a gene-based manner for two reasons: 1) the deleteriousness of
variants could come from protein-coding sequence changes or non-coding intronic regions
that contain regulatory elements. 2) Based on the previous simulation study (Daye, et al.),
the power of the analysis could be as low as 0.2 (sample size<200). By collapsing
singletons, one may benefit from increasing power. This idea is essentially similar as those
burden tests for rare CNV in GWAS and de novo mutations in sequencing study. Indeed,
the signal is identified mainly from the intronic regions of SETX in a collective manner of
those singletons.
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CHAPTER 6
POLYASEEKER: A PIPELINE FOR IDENTIFYING POLYA SITES

6.1 Introduction
Alternative polyadenylation (APA) of mRNA plays a crucial role in post-transcriptional
gene regulation. To date, however, no bioinformatics tools exist for identifying
polyadenylation cleavage sites from increasingly popular RNA-Seq data. This chapter
proposes a bioinformatics pipeline, PolyASeeker, to fill this void. The novelties of this
work include a probabilistic scoring scheme that takes sequencing quality into account to
select polyA containing reads, and utilizing the mating information in paired-end reads.
Simulation studies and applications to real data demonstrate that the proposed tool can
efficiently and precisely identify PolyA sites for the analysis of RNA sequencing data. It
may be expected that the knowledge of APA mechanisms and their roles in gene regulation
will be greatly enhanced with the aid of the tool as increasingly more RNA-Seq data
become available.

6.2 Methods

6.2.1 Score PolyA Reads by Incorporating Sequencing Quality
This section proposes a novel scoring method that takes sequencing quality into account to
select PolyA containing reads. For a sequence, different weights are given to the bases of
A, T, C and G as follows:
(

)

{
̅
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When considering sequencing error , the expected score for each base is computed as:

( )

(

)

( )

( ̅)

( ̅)

(

)

( ̅)

( )

where can be obtained from the Phred-scaled base quality score, Q, in FASTQ file, i.e.,

(

)

.

Each aligned read is scored by evaluating its unmapped region. Specifically, let L be the
length of the unmapped region, and then compute the summation of the expected score of
each base in the unmapped region as follows:

( )

∑

where

(

)

is an indicator of whether a base is A or not,

{

̅.
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( ̅)

6.2.2 Novel Method for Filtering Internal Priming
This section develops a novel method for filtering internal priming. It extends 20 bp from
each side of a candidate cleavage site, and examine this 40-bp genomic region in the
reference genome. If this region is A-rich then it suggests internal priming. The above
scoring scheme for evaluating PolyA reads can be similarly applied by setting
let

{

} be a one-dimensional array with

. Now

being the expected score of the

ith base in the sequence. It formulates the problem of seeking an A-rich segment in the
40-bp sequence as solving the maximum-subarray problem, namely, to find a nonempty
and contiguous subarray of X whose values give the largest sum (Bentley, 1984). It scores
the internal priming for each alignment in terms of the sum of its maximum-subarray.

Figure 6.1 Illustration of PolyASeeker. A) Pipeline: PolyASeeker supports widely used
input and output file formats and integrates four steps from mapping to clustering, making
the tool easy to use. B) Filter contribution: the performances of leaving one filter out
(dashed lines) are worse than that of using all three filters (solid line), suggesting the
individual contribution to the improvement of PolyA site predictions made by each filter.
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6.2.3 Pipeline of Identifying PolyA Sites from RNA-Seq
The PolyASeeker pipeline is shown in Figure 6.1. PolyASeeker accepts raw reads and a
reference genome in their popular formats, fastq and fasta, respectively, as input. The short
reads are first mapped using Bowtie2 (Langmead and Salzberg, 2012) local model, which
does not require reads to align end-to-end. This feature is particularly suitable for aligning
PolyA containing reads. Next, for each alignment, PolyASeeker scores its unmapped
region by taking into account sequencing quality and selects candidate reads above a
pre-specified threshold (7.8 as default). The genomic loci with screened mapped reads are
considered as PolyA site candidates. For these candidate loci, PolyASeeker removes
potential false positives by applying the following three filters. (1) Read length filter: It
requires the length of the mapped region for a PolyA containing read be greater than a
threshold, to ensure the mapping accuracy. (2) A novel internal priming filter to reduce
false positives introduced by A-rich regions in the genome. (3) Supportive reads filter:
PolyASeeker counts how many PolyA reads support a PolyA site candidate and filters out
low confident ones. All these filters contribute to enhance PolyA site prediction
performance as shown in Figure 6.1. Finally, PolyASeeker clusters PolyA sites within a
24nt window by utilizing the snowball method (Tian, et al., 2005) and outputs a BED file.
PolyASeeker has several key merits. First, it is easy and convenient to use.
PolyASeeker integrates all necessary PolyA site analysis steps from mapping to clustering,
and provides a convenient one-stop solution. Users just need to provide raw sequencing
reads, supporting both pair-end and single-end libraries, and a reference genome to
perform the entire process for PolyA site predictions. The output file can be directly
uploaded to UCSC genome browser (http://genome.ucsc.edu/) or IGV (Robinson, et al.,
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2011) for visualization. Second, PolyASeeker is accurate and powerful, and demonstrates
the state-of-the-art performance, as shown in the simulation studies and real data analyses.
Third, PolyASeeker takes full advantage of existing powerful NGS tools, for example,
Bowtie2 (Langmead and Salzberg, 2012) and BEDTools (Quinlan and Hall, 2010), making
the pipeline so efficient that it can process large scale data feasibly.

Figure 6.2 Performance of PolyASeeker and the 8A-stretch method for simulated data.
With comparable Recall, PolyASeeker outperforms the 8A-stretch method in terms of
significantly improved Precision in all the simulation settings.
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6.3 Results

6.3.1 Simulation Studies
The simulation covered various RNA-Seq experiments using FluxSimulator (Griebel, et
al., 2012) to assess the performance of PolyASeeker. It considered four scenarios: 100bp
paired-end, 75bp paired-end, 100bp single-end and 75bp single-end. To simulate more
realistic error models, instead of using the default one in FluxSimulator, a custom error
model was created from an in-house RNA-Seq dataset from Illumina platform. The model
of

the

polyadenylation

process

in

FluxSimulator

was

generated

by

a

Weibull-approximation of the normal distribution with shape=2 and scale=300 to sample
random lengths of polyA tails of human. The Poly-dT priming RNA-Seq procedure was
performed and sequenced different reads depths, from 1M to 200M for all the four
scenarios.
The simulation considered only expressed transcripts (molecule>0), which
generated ~13,600 out of all the 34,102 transcripts in each simulated dataset. It defined the
ends of these expressed transcripts to be true PolyA sites. If a PolyA site prediction fell into
+/-5bp of a true site, the prediction was considered as a true positive (TP), and a false
positive (FP) otherwise. If a true site was not covered by any prediction correctly, it was
considered as a false negative (FN). The performance was evaluated by Precision, Recall
and F-score, defined as follows:

(
(
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The simulation compared the performance of PolyASeeker to a simple 8A-stretch
method. It found that PolyASeeker achieved comparable recall but much higher precision
among all the settings (Figure 6.2). It also found that the best mapping strategy in the
proposed pipeline performed better than the uniquely mapping strategy that was commonly
used in previous studies (Fu, et al., 2011; Ji, et al., 2011; Pickrell, et al., 2010) (Figure 6.3).

Figure 6.3 The best mapping strategy performs better than the uniquely mapping strategy,
especially for single-end data.
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Table 6.1 Summaries and Results of Five Real RNA-Seq Datasets
Data
Library
#Samples
Total reads
PolyA reads
PolyA sites
Known sites
Novel sites
FDR
Running time

Human Body
Map 2.0
2x50
paired-end
16
1,278,682,935
174,418
12,432
6,492(52.22%)
5,940(47.78%)
5.5%
~118.5h

Arabidopsis
Thaliana
2x101
paired-end
6
69,695,338
14,626
885
179(20.23%)
706(79.77%)
13.5%
~9.9h

Breast Cancer
75
single-end
3
31,026,769
16,139,436
89,475
56,148(62.75%)
33,327(37.25%)
5.6%
~4.1h

Saccharomyces
Cerevisiae
2x76
paired-end
2
23,742,737
118,562
4,991
497(9.96%)
4,494(90.04%)
13.6%
~3.5h

Sordaria
Macrospora
101
single-end
8
465,385,168
577,897
42,542
15.2%
~47h

6.3.2 Applications to Real NGS Data
PolyASeeker was applied to analyze five RNA sequencing datasets that cover different
representative RNA-Seq settings and species for demonstrating its performance: (1)
regular paired-end human tissue data, from the Illumina Human Body Map 2.0 project
(NCBI GEO: GSE30611), which profiled 16 different human tissues using 2x50
paired-end sequencing; (2) single-end breast cancer data, generated following a special
protocol by using modified oligo-d(T) tagged with sequencing primers to sequence polyA
containing reads (Fu, et al., 2011); (3) Plant data, using 2x101 paired-end sequencing, from
a recent Arabidopsis study (Ren, et al., 2012); (4) Yeast data from expression profiling of
Saccharomyces cerevisiae by 2x76 paired-end high throughput sequencing (Levin, et al.,
2010); and (5) 101 bp single-end RNA-Seq data for transcriptional landscape of fungal
development (Teichert, et al., 2012). The data summaries and analysis results are given in
Table 6.1. About 37%, 80% and 90% of the polyA sites identified by the proposed pipeline
are novel for human, plant and yeast, respectively, compared to the ones that have been
catalogued in the existing public PolyA databases (Human: PolyA-Seq (Derti, et al., 2012)
from UCSC genome browser, Arabidopsis: http://www.arabidopsis.org/ and Yeast:
PACdb, http://harlequin.jax.org/pacdb/). The high fraction of novel sites in plant and yeast,
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compared to human, is mainly due to the fact that the public PolyA databases for plant and
yeast are EST-based and have not been enriched by high throughput studies yet. This
highlights that the knowledge of PolyA sites among different species can be greatly
enhanced by applying the proposed tool to plentifully available RNA-Seq data. It also
estimated their false discovery rates (FDRs) following (Pickrell, et al., 2010). PolyASeeker
achieved a comparable FDR in the three non-human datasets and much lower FDRs in the
two human datasets than the one obtained in (Pickrell, et al., 2010).
The next was to compare the predicted polyA sites with those found by the simple
8A-stretch method (Tian, et al., 2005). To this end, the 8A-stretch method was applied to
the same five real datasets. Comparable results were achieved for yeast and fungi data, and
much better results for human and plant data in terms of the number of identified PolyA
sites and the number of recovered alternative polyadenylated genes (Figure 6.4). It has
been found that, for the 2x50 paired-end Human Body Map 2.0 project, ~30% APA genes
were recovered by PolyASeeker whereas only ~13% APA genes were identified by the
rudimentary 8A-stretch method. The results also show that the sequencing depth of PolyA
containing reads would affect the number of identified APA genes. The breast cancer
dataset has about 10-fold more PolyA containing reads than the Human Body dataset
(Table 6.1). As shown in Figure 6.4, the breast cancer dataset reveals ~75% of genes that
produce alternative polyadenylated mRNAs, which is ~2.3 fold more than that of the
Human Body dataset. Taken together, these observations indicate that the analysis of
relative usages of sites in APA genes could be largely affected if employing different
sequencing protocols (leading to different numbers of PolyA containing reads) and
choosing different bioinformatics tools.
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Figure 6.4 Bar plot showing the number of genes with different numbers of PolyA sites
detected by PolyASeeker and the simple 8A-stretch method from five real datasets.
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Figure 6.5 The nucleotide composition surrounding polyadenlyation cleavage locations
identified by PolyASeeker in five real datasets.

Figure 6.5 shows the nucleotide composition surrounding polyadenylation
cleavage locations in each dataset, which is similar to previous studies (Jan, et al., 2011;
Ozsolak, et al., 2010; Sherstnev, et al., 2012). These summary statistics and results suggest
that the proposed pipeline can be applied to analyze RNA sequencing data accurately and
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efficiently. It will facilitate fully exploiting RNA-Seq data for gaining a better
understanding of alternative polyadenylation mechanisms.

6.4 Summary
In conclusion, this chapter has developed a useful bioinformatics pipeline, PolyASeeker, to
identify PolyA sites from RNA sequencing data. It is the first NGS bioinformatics tool to
detect PolyA sites. It may be expected that the knowledge of APA mechanisms and their
roles in gene regulation will be greatly enhanced with the aid of the proposed tool as
increasingly more RNA-Seq data become available.
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CHAPTER 7
A CHANGE-POINT MODEL FOR IDENTIFYING 3’UTR SWITCHING

7.1 Introduction
Next-generation RNA sequencing offers an opportunity to investigate transcriptome in an
unprecedented scale. Recent studies have revealed widespread alternative polyadenalytion
(APA) in eukaryotes, leading to various mRNA isoforms differing in their 3’UTR, through
which, the stability, localization and translation of mRNA can be regulated. However, very
few, if any, methods and tools are available for directly analyzing this special alternative
RNA processing event. Conventional methods rely on annotation of polyadenylation sites;
yet, such knowledge remains incomplete, and identification of PolyA sites is still
challenging. The goal of this chapter is to develop methods for detecting 3’UTR switching
without any prior knowledge of PolyA annotations.
This chapter proposes using a change-point model for identifying 3’UTR
switching, which is the first available method that allows investigators to directly analyze
3’UTR length changes without being dependent on PolyA site information. To determine
whether a 3’UTR is shortening or lengthening to a certain extent, it further develops an
additional testing procedure to make directional decisions. It has been shown that this
directional procedure can control the mixed directional FDR (mdFDR) at a pre-specified
nominal level. Simulation studies in various settings and applications to two real NGS data
sets have demonstrated that the proposed change-point model and the testing framework
are powerful and accurate. This tool will allow investigators to analyze next-generation
RNA sequencing data in an effective and efficient way.
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7.2 Methods

7.2.1 Change-point Model for 3’UTR Switching
The 3’UTR switching problem and the change-point model are illustrated via a toy
example in Figure 7.1. Assume there are two 3’UTR isoforms, isoform 1 and isoform 2,
ending with a distal and proximal PolyA site, respectively. These two PolyA sites define
the common and extended regions. The expression ratio of the two isoforms across two
conditions, treatment and control, can be quantified by the percentage of read counts from
the treatment condition (Figure 7.1(C)). It is expected a constant ratio throughout the whole
3’UTR (pi = C, for i=1,..,T), if the usage of isoforms under these two conditions is
identical. A ratio change at a certain position

implies a ratio change between two

isoforms, which is so-called 3’UTR switching. The goal is to test the null hypothesis H0
that the ratio pi is constant against the alternative hypothesis that, for some point in the
3’UTR, the ratio changes from p0 to

,

{

When the change-point location is known, e.g., based on isoform knowledge if
available, detecting the change is straightforward. However,

,

, and, most importantly,

, are unknown in this problem.
The model starts with a setup for the sequenced reads on 3’UTR with length . Let
{

} be the number of reads whose first base maps to the left of base location t of a

given 3’UTR under the treatment condition. Similarly, let {
such reads under the control condition. Denote
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and

} be the number of

to be the total number of reads

{

in the treatment and control conditions, respectively. Let
{

} and

} be the event locations for processes { } and { }, namely, U and

V are the mapped positions of reads from the treatment and control samples. Let
be the total number of reads combined from treatment and control samples, and
then obtain combined event locations {

}. Define an indicator variable

to denote whether an event is a realization of the treatment process or control process as:

{
{

{

}
}

For any short read in the combined process, use the term “success” to refer to
, that is, the read is from the treatment process. Hence, following (Worsley, 1983) ,
define a change-point model on the indices {

} for read counts by the binomial

log-likelihood function. Considering a candidate change point at

, for

generalized likelihood ratio statistic is

∑
[

̂

{

̂

]

(
̂

∑ {
[

̂

)

̂

]

̂
(

)

}
̂
̂

}

where ̂ , ̂ and ̂ are the maximum likelihood estimates of success probabilities:

̂

∑

̂

̂
∑
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∑

, a

Figure 7.1 Illustration and notations of the change-point model for 3’UTR switching
problem.

Note that this is an exact binomial generalized likelihood ratio statistic and can help
to quantify the ratio change. Because the change-point location is unknown, the statistic
for all candidate loci =2, …, T-1 can be computed , and find the one yielding the maximal
change. The solution is

̂

7.2.2 General Iterative Procedure for Calculating P-value
This section seeks to compute the significance p-value for the maximum test statistic. To
this end, following (Worsley, 1983) it employs a general iterative procedure to calculate
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how likely the maximum likelihood ratio statistic L would be less than
(

̂ ),

̂,

denoted as

under the null hypothesis.

For the combined process in section 7.2.1, let

and

be the total numbers of

successes (from the treatment process) at intervals [1, k-1] and [k, T], respectively,
(k=2,...,T-1). The likelihood ratio test statistic
, and

is fixed, then

Therefore, given

̂

{
For

̂

can be expressed as
{

for suitable choices of
̂

. Given that

depends only on Sk.

and the test statistics, events of

events of the form
and

depends only on Sk and

̂

}.
( )

, define

(⋂

̂

|

) so that the

p-value can be derived as follows:
1)

( )

.
( )

2)
( )

by
( )

∑

(

)

) (

)

∑

(

)

(

)(

3) A final iteration for k=T at v=S will produce
4)

}

(
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̂)

( ) equal to
(

(
̂ ).

̂ ).

7.2.3 Directional Multiple Testing Procedure
If the usage of the long isoform increases, it is called lengthening, and, if it decreases,
shortening. Identifying shortening or lengthening events may be critical for downstream
analysis, such as analyzing miRNA target sites. The significance computed in the previous
section is for a two-sided test. That is to say, when the null hypothesis is rejected, it can
only state that there is a change, either lengthening ( ̂

̂ ) or shortening ( ̂

̂ ). In

practice, upon rejecting the null H0, one may often conclude that the change is either
lengthening or shortening based on the sign of ( ̂

̂ ). There is a chance that this decision

strategy will make a false statement about the sign, which is termed as a directional error,
or a type III error (Benjamini, et al., 2005). It is desirable to control this error when making
directional conclusions, which may not be negligible when a large number of tests are
conducted simultaneously. In the applications of this chapter, it often tests for tens of
thousands of genes at a time.
In the multiple-testing field, it is often argued that an exact null hypothesis is never
true in reality; instead, more likely only significant differences matter (Benjamini, et al.,
2005; Williams, et al., 1999). Here for the 3’UTR switching problem, small change may
happen by chance and is irrelevant to the phenotype of interest. Dramatic change may be
more robust and easier to replicate. Therefore focusing on dramatic change is particularly
meaningful as it often has only one or very few replicates in RNA-Seq experiments.
This section proposes to use the odds ratio (OR) at the estimated change point ̂ to
measure the change direction and magnitude, reasoning that the proposed method
essentially chooses the location that gives the strongest association in a 2×2 contingency
table among all possible locations. Thus, it performs Fisher’s exact test at the estimated
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change point ̂ to make such directional decisions. It formulates this problem as controlling
false discoveries within the multiple-testing framework. Using a similar definition as in
(Guo, et al., 2010), denote the mixed directional FDR (mdFDR) to be a combination of two
parts. One is the false discovery rate (FDR), resulted from the change-point testing
procedure. The other is the pure directional FDR (dFDR), derived from Fisher’s exact test,

{

⋁

}

{

⋁

}

{

⋁

}

where C is the number of falsely rejected true null hypotheses and R is the total number of
rejected hypotheses among H1, …, Hm. F denotes the total number of false null hypotheses
among H1, …, Hm that are correctly rejected while at least one directional error has been
made when deciding upon the signs of the components.
To control mdFDR, the expected proportion of Type I and directional errors among
all the rejections, this section proposes a directional testing procedure as follows:
1) Apply the BH method at level α to test whether there is a significant change among
all the m hypotheses.
2) Let R denote the number of hypotheses rejected.
3) For every i=1,…, R, perform one-sided Fisher’s exact test for testing OR>d (d≥1).
4) If Fisher’s exact test has a p-value

, then reject the null hypothesis.

It is shown that a similar BH procedure using the same two-sided p-value twice can
control the mdFDR at level

(Benjamini, et al., 2005). The directional testing procedure

proposed here has its novel extension in comparison with the BH procedure in (Benjamini,
et al., 2005). Specifically, the same significance p-values are re-used in testing direction
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and controlling directional errors in (Benjamini et al. 2005); in contrast, this procedure
employs an additional one-sided Fisher’s exact test for detecting dramatic change and the
rejection is based on these new p-values. It can be seen in the simulation studies that the
new testing procedure can control mdFDR at the nominal level. It is noted that when d=1,
the one-sided test determines the direction of 3’UTR changes. The user may set d to be
much larger than 1 to detect genes with more dramatic 3’UTR changes.

7.3 Simulation Studies
This section first presents simulation results to demonstrate the performance of the
change-point model. Assume there are two 3’UTR isoforms with different ending PolyA
sites as shown in Figure 7.1. The gene expression level ratio before and after the change
point (Figure 7.1(C)) will critically influence how difficult the change can be detected. So
it generated the 3’UTR with different expression ratios under two conditions. Specifically,
under condition 1, the entire 3’UTR has a constant expression level; whereas, under
condition 2, the expression level was increased by K-fold in the common region and the
extended region remained the same as in condition 1. Gene expression level was measured
in RPKM (Reads Per Kilobase per Million mapped reads (Mortazavi, et al., 2008)). It
simulated two constant expression levels RPKM=1 and RPKM=2 for condition 1. These
two RPKM values are commonly used for determining expressed genes in RNA-Seq real
data analyses (Ji, et al., 2011; Zhang, et al., 2013). It assumed that the total number of
mapped reads was 100 million/sample and the 3’UTR length was 1000bp. It considered
three possible change points at 250bp, 500bp and 750bp of the 3’UTR. It varied the fold
change K in the common region from 2 to 4 with increments of 0.5. The null distribution
was simulated by setting K=1 for estimating type I errors. It simulated 500 3’UTRs with

70

change (K>1) and 500 3’UTRs without change (K=1) to estimate the power and FDR of
the proposed method, respectively. FDR nominal level=0.05 was set. The simulation was
repeated 50 times, and it reported the averaged power and FDR.

Figure 7.2 Power and FDR evaluation of the change-point model at the nominal level
FDR=0.05.
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Figure 7.3 Power and mdFDR evaluation of the directional testing procedure at the
nominal level mdFDR=0.05.

The simulation results are summarized in Figure 7.2. It can be seen that FDR was
controlled at the nominal level=0.05 in all settings, suggesting that the proposed method is
a valid testing procedure. Moreover, it can be found that the fold change, expression level
and change point position all influence 3’UTR switching detection. First, the power of the
proposed method increases with the fold change from small to large. This is expected
because the change is more likely to be detected when the signal becomes stronger.
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Second, the power increases when the gene expression level increases. Under the same fold
change, the power of RPKM=2 is always higher than that of RPKM=1, suggesting that
increasing the number of reads that are covered in the 3’UTR will also benefit change
detection. Third, the position of the change point has an impact on the performance too.
The change point in the middle yielded the highest power, compared to the change points
close to the two ends.
Next, the power and mdFDR are evaluated for the proposed two-step testing
framework. To simulate alternative hypotheses with mixed odds ratios, it used similar
simulations as above but with the following modifications. For the 500 3’UTRs with fold
change, they were divided into two groups with 250 each. The fold change for the first
group is uniformly distributed from 1 to 3, and the second group is uniformly distributed
from 3 to 5. d=1 and d=3 to test the changes was set with OR>1 and OR>3, respectively.
The proposed directional testing procedure at mdFDR level=0.05 was applied.
As seen in Figure 7.3, the proposed testing framework is able to control mdFDR at
the nominal level=0.05 for all the settings. Similarly, the power increases when the
expression level doubles from RPKM=1 to RPKM=2, and the change point at the middle
position is easier to detect than those closer to the two ends. It is noted that when the
hypothesized odds ratio is changed, the results change accordingly. For example, if the
interest is detecting the 3’UTRs with OR>3 by setting d=3, the testing procedure then
favors the second group of 3’UTRs with OR~
in the first group with OR~

(

(

) and would not reject the 3’UTRs

). When setting d=1 for testing the 3’UTR changes

with OR>1, the 3’UTRs in the group with OR~

(

) are easier to detect because the

signal is relatively stronger than that of d=3. This explains the power difference between

73

testing OR>1 and OR>3 as shown in Figure 7.3. In summary, it is easier to capture the
switching events when the OR is higher, the expression level is higher, or the change-point
is closer to the middle.

7.4 Real Data Applications

7.4.1 Application to Regular RNA-Seq Data
The proposed method has been applied to analyze regular RNA-Seq data that have been
commonly produced to profile transcriptome changes. MYC is a notable transcriptional
factor that has been frequently activated in many human cancers with profound cellular
influence. Although MYC-binding sites and target genes have been documented
extensively in the past decade, thanks to the widespread application of high-throughput
technology, the role of MYC and MYC target genes in androgen-controlled breast cancer
growth remains unclear. To elucidate MYC regulatory network in molecular apocrine
breast cancers, Ni and colleagues employed RNA-Seq to profile transcriptome changes
before and after MYC knockdown by siRNA in MDA-MB-453 breast cancer cells with
androgen stimulation (Ni, et al., 2013). In summary, they transfected MDA-MB-453 breast
cancer cells with control (siCtrl) or MYC siRNA (siMYC) for 48 h, followed by treatment
with 10nM DHT (the most potent androgen) or vehicle (veh) for 6 h, resulting in three
conditions: siCtrl-veh, siCtrl-DHT and siMYC-DHT. High-throughput 50bp single-end
sequencing was performed on Illumina HiSeq 2000 platform for each sample, generating
total numbers of short reads ranging from ~26 million to ~39 million. Following the
authors, two comparisons was made, siCtrl-DHT vs siCtrl-veh and siMYC-DHT vs
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siCtrl-DHT, but to detect 3’UTR shortening events instead of gene expression level
changes.

Figure 7.4 Examples of two MYC-dependent 3’UTR shortening events. The vertical lines
indicate the estimated change points predicted by the proposed model.
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The dataset was downloaded from NCBI Gene Expression Omnibus (GEO)
(http://www.ncbi.nlm.nih.gov/geo/) under GSE45202. The raw reads were aligned to hg19
reference genomes using a conventional RNA-Seq aligner Tophat (Trapnell, et al., 2009)
v1.3.1 with default parameters. Coverage filter can help to reduce false positives and is a
heuristic strategy commonly used in existing RNA sequencing tools and analyses.
Following MISO (Katz, et al., 2010), the analysis required that each 3’UTR should have at
least 20 supporting reads in both samples, leading to 8052 and 7878 genes in the two
comparisons, respectively, for further analysis. The proposed method was applied to detect
shortening events with odds ratio>2 at an mdFDR level of 0.05. The analysis identified 947
shortening 3’UTRs in siCtrl-DHT vs siCtrl-veh and 1524 shortening 3’UTRs in
siMYC-DHT vs siCtrl-DHT, respectively, with 461 genes in common. The 1063 genes
unique in the comparison of siMYC-DHT vs siCtrl-DHT but not siCtrl-DHT vs siCtrl-veh
may be associated with MYC knockdown given the DHT treatment. Figure 7.4 shows two
examples of significant MYC-dependent shortening events, LDHA and OGDH, on the
UCSC genome browser, demonstrating that the proposed method worked well in detecting
such 3’UTR switching without relying on any PolyA annotations. It can be observed that a
highly non-uniform distribution of data in the 3’UTR, a common phenomenon in
RNA-Seq data which may be caused by PolyA mRNA selection bias (Wang, et al., 2009).
The PolyA track in the genome browser was included, which showed the annotated PolyA
sites from the PolyA_DB. It can be seen that dramatic changes before and after the
predicted change-points. Clearly, the two genes LDHA and OGDH tend to use the
proximal PolyA site instead of the distal site in siMYC-DHT. These change-points are also
consistent and supported by the PolyA sites annotated in the PolyA_DB. Together, these
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results suggest that the proposed method works well to detect 3’UTR switching without
relying on any PolyA annotations.
LDHA catalyzes the conversion of L-lactate and NAD to pyruvate and NADH in
the final step of anaerobic glycolysis. It has been shown to be highly correlated with breast
cancer growth (Wang, et al., 2012). OGDH encodes one subunit of the 2-oxoglutarate
dehydrogenase complex that catalyzes the overall conversion of 2-oxoglutarate
(alpha-ketoglutarate) to succinyl-CoA and CO(2) during the Krebs cycle. It also plays an
important role in breast cancer cells (Qattan, et al., 2012). These shortening genes may be
worthwhile for further biological study, because, the loss of distal region, if containing
miRNA target sites, may help escape degradation destiny or translational repression.
A gene set enrichment analysis (GSEA) of these 1063 MYC-dependent shortening
genes was conducted using a hypergeometric test. The canonical pathways definitions
were

downloaded

from

the

Molecular

Signatures

Database

(http://www.broadinstitute.org/gsea/msigdb/index.jsp). The results are summarized in
Table 7.1. It has been suggested that MYC plays a crucial role in several aspects of cellular
function, such as metabolism, growth, replication, differentiation and apoptosis (Ni, et al.,
2013). These pathway results suggest very interesting transcription relevant functions of
these 1063 MYC-dependent shortening genes, such as splicing, intron processing and
transcript elongation. These genes are primarily associated with mRNA processing and
gene expression, which are critical in cancer development (David and Manley, 2010;
Sotiriou, et al., 2006). The original studies (Ni, et al., 2013) focused on conventional
differential expression analysis. Capturing 3’UTR switching from the same RNA-Seq data
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set using the proposed method would shed additional light on cancer transcriptome
regulations and suggest new roles of MYC.

Table 7.1 Significantly Enriched Canonical Pathways in Analysis of the Breast Cancer
Dataset of (Ni, et al., 2013) at FDR=0.05
Canonical Pathway

P Value

REACTOME_MRNA_SPLICING

3.74E-05

REACTOME_GENE_EXPRESSION

4.99E-05

REACTOME_PROCESSING_OF_CAPPED_INTRONCONTAINI 7.74E-05
NG_PRE_MRNA
BIOCARTA_PROTEASOME_PATHWAY

1.06E-04

REACTOME_FORMATION_AND_MATURATION_OF_MRNA
_TRANSCRIPT

1.32E-04

REACTOME_METABOLISM_OF_PROTEINS

2.51E-04

REACTOME_ELONGATION_AND_PROCESSING_OF_CAPPE
D_TRANSCRIPTS

2.55E-04

KEGG_OXIDATIVE_PHOSPHORYLATION

3.35E-04

REACTOME_TRANSLATION

6.15E-04

KEGG_CARDIAC_MUSCLE_CONTRACTION

7.68E-04

REACTOME_INFLUENZA_LIFE_CYCLE

9.18E-04

To compare to existing methods applicable for the 3’UTR switching analysis but
relying on PolyA annotations, MISO was also run (Katz, et al., 2010) (version 0.4.1 with
default parameters) to analyze this RNA-Seq dataset for identifying 3’UTR shortening
events. It filtered tandem 3’UTR events following the MISO manual as follows: (a) at least
1 inclusion read, (b) 1 exclusion read, such that (c) the sum of inclusion and exclusion
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reads is at least 10, and (d) the Δ Ψ is at least 0.2 and (e) the Bayes factor is at least 10, and
(a)-(e) are true in one of the two samples. MISO didn’t output any tandem 3’UTR events,
although it did report other alternative splicing events, such as skipped exons, intron
retentions, etc. This shows that methods depending on PolyA annotations may suffer from
low power in 3’UTR switching analysis. The capability of the method for detecting 3’UTR
switching will fill a void among current alternative splicing and processing analysis tools.

Figure 7.5 Examples of two shortening events that were identified by the method but
missed by the linear trend test. The vertical lines indicate the change-points predicted by
the proposed model.
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7.4.2 Application to Special RNA-Seq Data
Another breast cancer dataset (Fu, et al., 2011) was analyzed to highlight the flexibility of
the proposed method to handle special RNA sequencing data. To improve efficiency of
capturing APA sites, Fu and colleagues developed a novel strategy to sequence only reads
with Poly(A) tails followed by a linear trend test method for analyzing APA site switching
(Fu, et al., 2011). Specifically, they modified oligo-d(T) tagged with sequencing primers
after PCR to sequence polyadenylated reads. They performed the SAPAS method to
profile APA sites of human breast cancer lines and compared with normal cell lines,
generating in total ~31 million short reads with 75bp length from the Illumina platform.
The

dataset

was

downloaded

from

the

NCBI

Sequence

Read

Archive

(http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi) (accession number SRA023826). PolyA
containing reads cannot be mapped to the genome directly. Therefore, Bowtie2 (Langmead
and Salzberg, 2012) was used by local model to align those PolyA containing reads,
because this model does not require end-to-end mapping. The proposed method was
applied to identify 3’UTR shortening events. The authors reported their results at FDR
level=0.01. To make a comparison, shortening events at the same mdFDR level of 0.01 for
OR>1 were reported. It has been identified 972 shortening events in the breast cancer cell
line (MCF_7) in comparison with the control sample (MCF_10A). Their linear trend test
method was conservative according to the authors, and detected only 428 shortened
3’UTRs (Fu, et al., 2011). It has been found that 85% of their shortening genes were also
detected as shortening by the proposed method. The larger numbers of 3’UTR shortening
events it identified under the same significance level suggest the higher power of the
proposed method.
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Table 7.2 Significantly Enriched Canonical Pathways in Analysis of the Breast Cancer
Dataset of (Fu, et al., 2011) at FDR=0.05
CANONICAL PATHWAY

P Value

REACTOME_MRNA_SPLICING

3.83E-05

REACTOME_ELONGATION_AND_PROCESSING_OF_CAPPED_T
RANSCRIPTS

1.78E-04

KEGG_CELL_ADHESION_MOLECULES_CAMS

1.88E-04

KEGG_SPLICEOSOME

2.11E-04

REACTOME_DIABETES_PATHWAYS

2.25E-04

BIOCARTA_EIF_PATHWAY

4.07E-04

REACTOME_PROCESSING_OF_CAPPED_INTRON_

5.36E-04

CONTAINING_PRE_MRNA
REACTOME_FURTHER_PLATELET_RELEASATE

7.13E-04

To demonstrate the accuracy of these findings, the four genes that were validated in
their studies were examined. All the four genes, DDX5, SEC61A1, HSBP1 and
FAM134A, were detected to be shortening in MCF_7 by the proposed method. The
shortenings of these four genes were all experimentally confirmed (see the PCR results in
the Supplementary of (Fu, et al., 2011)). Moreover, visualization of the identified
shortening events highlighted the accuracy of the prediction. Figure 7.5 shows two genes
OAZ1 and SDC1 that were missed by the linear trend method but demonstrated clear
shortening patterns. Both genes are known to be related with cancer (Kastl, et al., 2010;
Nikolova, et al., 2009). Finally, the GSEA for these 972 shortening genes was conducted.
The results are summarized in Table 7.2. Interestingly, it has also found the mRNA
splicing pathway to be the most significantly enriched in this breast cancer dataset, as in the
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first breast cancer dataset that analyzed in the previous section. In particular, these genes
are related to splicesome, a large ribonucleoprotein complex that guides pre-mRNA
splicing in eukaryotic cells. Recent studies have demonstrated the contribution of
splicesome as a core component in oncology (Quidville, et al., 2013) and its role in
determining 3’UTR length (Berg, et al., 2012). Taken together, these results indicate the
accuracy of the proposed method in capturing 3’UTR switching. Overall, this real data
application highlights the flexibility of the proposed method for analyzing NGS data that
are specially generated to sequence and capture polyadenlyation cleavage sites.

7.5 Conclusion and Discussion
This chapter proposes a change-point model based on a generalized likelihood ratio
statistic for identifying 3’UTR length change in the analysis of next-generation RNA
sequencing data. It develops a directional multiple testing procedure for identifying
dramatic shortening or lengthening events. The numerical performances of the approach
are investigated using both simulated and real data. The results show that the proposed
method is powerful, accurate, and flexible for analyzing various types of next-generation
RNA sequencing data.
The proposed method can be improved in several ways. First, one limitation is that
the current method cannot handle sample replicates. The extension is to compute joint
likelihood over multiple samples, assuming the same change-point across samples but
allowing ̂ , ̂ , and ̂ to vary for different sample comparisons. Second, assume there are
only two isoforms with one change point. The extension can be done for multiple isoforms
with K>1 change points. In principle, it may search similarly for the K points that yield the
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most significance with computational complexity of O(LK), where L is the whole UTR
length. It may further assume K is unknown and determine it using model selection (Shen
and Zhang, 2012). Third, statistical inference of confidence estimates is as important as
point estimates. For example, the confidence intervals on the estimated change points
could provide more information as needed for some downstream analyses, such as
determining the loss/gain of miRNA target sites. This can be obtained based on the values
accepted by a level α of likelihood ratio test (Worsley, 1986).
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CHAPTER 8
CONCLUSION AND FUTURE WORK

This dissertation focuses on the development of computational methods for NGS data
analyses. The main contributions of this dissertation are as listed below:
First, a statistical tool, SNVer, has been developed for calling common and rare
variants in analysis of pooled or individual DNA-Seq data. It formulates variant calling as a
hypothesis testing problem and employ a binomial-binomial model to test the significance
of observed allele frequency against sequencing error. The reported p-values for candidate
loci are particular desirable for multiplicity control. SNVer runs very fast, making it
feasible for analyzing high-throughput NGS data.
Second, a graphical user interface(GUI)-based tool, SNVerGUI, has been
implemented based upon SNVer model. Compared with other current methods for variant
calling, SNVerGUI is unique in that it is applicable to both individual and pooled DNA
sequencing data. It allows users who do not have bioinformatics expertise to perform
sophisticated variant detection by a simple and user-friendly desktop tool.
Third, a gene-based genome-wide screening method based on collapsing singletons
in a whole-genome sequencing dataset has been studied. It has been demonstrated that this
strategy can boost signals for associating rare variants in the NGS sequencing analysis.
Fourth, a novel bioinformatics pipeline, PolyASeeker, has been developed to fill
the void of identifying polyadenylation cleavage sites from increasingly popular RNA-Seq
data. The novelties include a probabilistic scoring scheme to select candidate reads and use
the mating information in paired-end data.
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Finally, a change-point model based on a likelihood ratio test has been proposed to
detecting 3’UTR switching from RNA-Seq data. This is the first available method that
allows users to directly analyze 3’UTR length changes without relying on any prior
information of PolyA sites. It also allows user to make directional decisions and control
mixed directional FDR (mdFDR) at a pre-specified level.
Future work lies in the following directions:
First, it has been shown that there remains significant discrepancy in SNV and indel
calling between many of the currently available variant-calling pipelines under
near-default software parameterizations (O'Rawe, et al., 2013). This, therefore,
demonstrates that further improvement of variant calling algorithm is necessary, especially
for indel detection.
Second, the association study in this dissertation focuses on only genic regions
using conventional gene annotation, which makes up little more than 1% of the genome.
The recent annotation made by the ENCODE consortium has included more than 70,000
“promoter” regions and nearly 400,000 “enhancer” regions that regulate expression of
distant genes, which account for roughly 80% of the genome (Dunham, et al.,
2012)(Dunham, Kundaje et al. 2012). This new knowledge can be used in future analysis.
Third, in addition to 3’UTR switching analysis, the proposed change-point method
can also be extended to other applications. For example, one can merge together the
multiple 3’UTRs of a gene, if any, to perform alternative last exon analysis. Moreover, if
input vector is the coverage of entire exon regions of a gene, the proposed method can also
detect premature cleavage and polyadenylation (PCPA) events, another set of interesting
biological phenomena that has received much attention recently (Kaida, et al., 2010).
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These phenomena can also be computationally confirmed by identifying PolyA sites using
PolyASeeker.
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